{"content":"<li class=\"n-box-item date-title\" data-end=\"1548305999\" data-start=\"1548219600\" data-txt=\"Monday, December 23, 2019\">Wednesday, January 23, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3425413\" data-ts=\"1548282906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZPN\" target=\"_blank\">AZPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425413-lrcx-xlnx-uri-and-ctxs-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LRCX, XLNX, URI and CTXS among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/AZPN' title='Aspen Technology Inc.'>AZPN</a> <font color=\"green\">+9.9%</font>. <a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color=\"green\">+8.4%</font>. <a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color=\"green\">+7.1%</font>. <a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a> <font color=\"green\">+6.1%</font>. <a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a> <font color=\"green\">+6.0%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a> <font color=\"red\">-10.9%</font>. <a href='https://seekingalpha.com/symbol/LAUR' title='Laureate Education'>LAUR</a> <font color=\"red\">-8.8%</font>. <a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color=\"red\">-7.1%</font>. <a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a> <font color=\"red\">-6.1%</font>. <a href='https://seekingalpha.com/symbol/PTC' title='PTC Inc.'>PTC</a> <font color=\"red\">-6.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425413\" data-linked=\"LRCX, XLNX, URI and CTXS among notable after hour movers\" data-tweet=\"$AZPN $AZPN $XLNX - LRCX, XLNX, URI and CTXS among notable after hour movers https://seekingalpha.com/news/3425413-lrcx-xlnx-uri-and-ctxs-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425413-lrcx-xlnx-uri-and-ctxs-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425411\" data-ts=\"1548282663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STM\" target=\"_blank\">STM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425411-semi-stocks-move-after-earnings-trio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semi stocks move after earnings trio</a></h4><ul><li>Chip and semi equipment stocks gain after the positive earnings reports from peers <a href=\"https://seekingalpha.com/news/3425345-lam-resarch-plus-7-percent-q2-beats-5b-buyback\" target=\"_blank\">Lam Research</a>, <a href=\"https://seekingalpha.com/news/3425365-xilinx-plus-8-percent-q3-beats-upside-guide\" target=\"_blank\">Xilinx</a>, and <a href=\"https://seekingalpha.com/news/3425407-teradyne-plus-6_5-percent-q4-beats-line-guide\" target=\"_blank\">Teradyne</a>.</li><li>On the move: (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a>) <font color=\"green\">+3.6%</font>; (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"green\">+0.8%</font>; (NASDAQ:<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a>) <font color=\"green\">+1.3%</font>; (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) <font color=\"green\">+2.7%</font>.</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425411\" data-linked=\"Semi stocks move after earnings trio\" data-tweet=\"$STM $STM $INTC - Semi stocks move after earnings trio https://seekingalpha.com/news/3425411-semi-stocks-move-after-earnings-trio?source=tweet\" data-url=\"https://seekingalpha.com/news/3425411-semi-stocks-move-after-earnings-trio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425408\" data-ts=\"1548282199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFSI.PC\" target=\"_blank\">AFSI.PC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425408-amtrust-financial-series-c-preferred-drop-46-after-delisting-announced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmTrust Financial series C preferred drop 46% after delisting announced</a></h4><ul><li>AmTrust Financial Services' (NYSE:<a href='https://seekingalpha.com/symbol/AFSI.PC' title='AmTrust Financial Services Inc Deposit Shs Repr 1/40th 7 5/8 % Non-Cum Pfd Shs Series C'>AFSI.PC</a>) board approves <a href=\"https://seekingalpha.com/pr/17385418-amtrust-voluntarily-delist-deregister-series-preferred-stock-subordinated-notes\" target=\"_blank\">voluntarily delisting </a>of all six series of preferred stock and two series of subordinated notes from the NYSE.</li><li>AmTrust Financial Services Series C Preferred have fallen 46% to close at $8.63 on Jan. 23, down from $15.96 on Jan. 18 before the delisting announcement was made.</li><li>The company said the administrative costs and burdens associated with maintaining the listings on the NYSE and the registration exceed the benefits given the small number of record holders and low daily trading volume.</li><li>On Jan. 22, AmFin Financial, the former holding company of AmTrust Bank,<a href=\"https://seekingalpha.com/pr/17387790-amfin-financial-corporation-successfully-completes-plan-reorganization-will-explore-future\" target=\"_blank\"> completed its plan of reorganization </a>adopted in 2011 as part of its bankruptcy case filed in 2009.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3420446-maiden-holdings-return-700m-unearned-premium-amtrust\" target=\"_blank\">Maiden Holdings to return about $700M unearned premium to AmTrust</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425408\" data-linked=\"AmTrust Financial series C preferred drop 46% after delisting announced\" data-tweet=\"$AFSI.PC - AmTrust Financial series C preferred drop 46% after delisting announced https://seekingalpha.com/news/3425408-amtrust-financial-series-c-preferred-drop-46-after-delisting-announced?source=tweet\" data-url=\"https://seekingalpha.com/news/3425408-amtrust-financial-series-c-preferred-drop-46-after-delisting-announced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425407\" data-ts=\"1548282092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TER\" target=\"_blank\">TER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425407-teradyneplus-6_5-on-q4-beats-in-line-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teradyne +6.5% on Q4 beats, in-line guide</a></h4><ul><li>Teradyne (NYSE:<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a>) <font color=\"green\">gains 6.5%</font> on Q4 beats with revenue up 9% Y/Y. In-line Q1 guidance has revenue of $460M to $490M (consensus: $481.65M) and EPS of $0.39 to $0.47 (consensus: $0.46).</li><li>Earnings call is tomorrow at 10 AM ET with a webcast available <a href=\"http://investors.teradyne.com/events-presentations\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17389642-teradyne-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425395-teradyne-beats-0_14-beats-revenue\" target=\"_blank\">Teradyne beats by $0.14, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425407\" data-linked=\"Teradyne +6.5% on Q4 beats, in-line guide\" data-tweet=\"$TER - Teradyne +6.5% on Q4 beats, in-line guide https://seekingalpha.com/news/3425407-teradyneplus-6_5-on-q4-beats-in-line-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3425407-teradyneplus-6_5-on-q4-beats-in-line-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425395\" data-ts=\"1548281437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TER\" target=\"_blank\">TER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425395-teradyne-beats-0_14-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teradyne beats by $0.14, beats on revenue</a></h4><ul><li>Teradyne (NYSE:<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a>): Q4 Non-GAAP EPS of $0.63 <span style=\"color:green\">beats by $0.14</span>; GAAP EPS of $0.79 <span style=\"color:green\">beats by $0.35</span>.</li><li>Revenue of $520M (+8.6% Y/Y) <font color=\"green\">beats by $25.83M</font>.</li><li>Shares <font color=\"green\">+4%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17389642-teradyne-reports-fourth-quarter-fiscal-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425395\" data-linked=\"Teradyne beats by $0.14, beats on revenue\" data-tweet=\"$TER - Teradyne beats by $0.14, beats on revenue https://seekingalpha.com/news/3425395-teradyne-beats-0_14-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425395-teradyne-beats-0_14-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425388\" data-ts=\"1548281081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTC\" target=\"_blank\">PTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425388-ptcminus-6-on-downside-q2-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC -6% on downside Q2 guidance</a></h4><ul><li>PTC (NASDAQ:<a href='https://seekingalpha.com/symbol/PTC' title='PTC Inc.'>PTC</a>)<font color=\"red\"> drops 5.5%</font> after Q1 results that beat estimates with revenue up 9% Y/Y but came with downside Q2 guidance with revenue of $310M to $315M (consensus: $324.2M) and EPS of $0.31 to $0.36 (consensus: $0.39).</li><li>FY19 guidance has revenue of $1.325B to $1.34B (consensus: $1.33B) and EPS of $1.75 to $1.85 (consensus: $1.70).</li><li>Revenue breakdown: Software, $299.4M (consensus: $283.3M); Service, $39.4M (consensus: $39.9M).</li><li>Earnings call started at 5 PM with a webcast available <a href=\"https://investor.ptc.com/investor-relations\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17389447-ptc-announces-first-quarter-fiscal-year-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425294-ptc-beats-0_15-beats-revenue\" target=\"_blank\">PTC beats by $0.15, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425388\" data-linked=\"PTC -6% on downside Q2 guidance\" data-tweet=\"$PTC - PTC -6% on downside Q2 guidance https://seekingalpha.com/news/3425388-ptcminus-6-on-downside-q2-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3425388-ptcminus-6-on-downside-q2-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425387\" data-ts=\"1548280968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSIC\" target=\"_blank\">HSIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425387-schein-loses-100m-in-vet-business-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schein loses $100M in vet business; shares down 2% after hours</a></h4><ul><li>Medical products distributor Henry Schein (NASDAQ:<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a>) slips <font color=\"red\">2% </font>after hours following its <a href=\"https://www.sec.gov/Archives/edgar/data/1000228/000119312519014864/d686975d8k.htm\" target=\"_blank\">disclosure </a>that it is losing $100M in sales in its animal health unit. Key customer VCA, acquired by Mars in September 2017, intends to consolidate its purchases with one of Schein's competitors. Its distribution of Pet Partners products will also be affected.</li><li>The company says the sales are low margin and should not have a material effect on earnings.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425387\" data-linked=\"Schein loses $100M in vet business; shares down 2% after hours\" data-tweet=\"$HSIC - Schein loses $100M in vet business; shares down 2% after hours https://seekingalpha.com/news/3425387-schein-loses-100m-in-vet-business-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3425387-schein-loses-100m-in-vet-business-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425381\" data-ts=\"1548280496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425381-citrix-systemsminus-7-on-q4-beats-downside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix Systems -7% on Q4 beats with downside guide</a></h4><ul><li>Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) <font color=\"red\">drops 6.6%</font> aftermarket on Q4 beats with 3% Y/Y revenue growth and downside Q1 guidance with revenue of $700M to $710M (consensus: $726.61M) and EPS of $1.15 to $1.20 (consensus: $1.37).</li><li>FY19 guidance has revenue of $3.08B to $3.09B (consensus: $3.09B) and EPS of $6 (consensus: $6.06).</li><li>Revenue breakdown: Product and license, $210.8M (consensus: $212.9M); Subscription, $129.8M (consensus: $121.9M); Support and Services, $461.2M (consensus: $454M).</li><li>Earnings call started at 4:45 PM ET with a webcast available <a href=\"https://investors.citrix.com/investors/default.aspx\" target=\"_blank\">here.</a></li><li><a href=\"https://seekingalpha.com/pr/17389463-citrix-reports-fourth-quarter-fiscal-year-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425286-citrix-beats-0_07-beats-revenue\" target=\"_blank\">Citrix beats by $0.07, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425381\" data-linked=\"Citrix Systems -7% on Q4 beats with downside guide\" data-tweet=\"$CTXS - Citrix Systems -7% on Q4 beats with downside guide https://seekingalpha.com/news/3425381-citrix-systemsminus-7-on-q4-beats-downside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3425381-citrix-systemsminus-7-on-q4-beats-downside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425376\" data-ts=\"1548280051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425376-report-nielsen-restarting-sales-process-bids-due-friday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Nielsen restarting sales process, with bids due Friday</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>) is <a href=\"https://nypost.com/2019/01/23/ratings-giant-nielsen-wants-to-sell-itself-could-fetch-10b/\" target=\"_blank\">restarting the process to sell itself</a>, and should draw a premium, the <i>New York Post</i> reports.</li>    <li>Shares are <font color=\"green\">up 1.6%</font> after hours.</li>    <li>The company expects first-round bids due Friday from suitors that include former owners Blackstone Group (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a>) and Hellman &amp; Friedman, according to the report.</li>    <li>Blackstone's David Calhoun was CEO of Nielsen from 2006-2013, the Post notes, running the company for Blackstone, H&amp;F and Carlyle Group -- which listed Nielsen in a January 2011 IPO.</li>    <li>Nielsen's now worth $17.6B; the trio of P-E firms had bought Nielsen in 2006 for $11B.</li>    <li>Other interested firms, according to the report: <a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a>, TPG Capital and Bain Capital.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425376\" data-linked=\"Report: Nielsen restarting sales process, with bids due Friday\" data-tweet=\"$NLSN $NLSN $BX - Report: Nielsen restarting sales process, with bids due Friday https://seekingalpha.com/news/3425376-report-nielsen-restarting-sales-process-bids-due-friday?source=tweet\" data-url=\"https://seekingalpha.com/news/3425376-report-nielsen-restarting-sales-process-bids-due-friday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425375\" data-ts=\"1548280011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WVE\" target=\"_blank\">WVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425375-wave-life-sciences-readies-stock-offering-shares-down-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wave Life Sciences readies stock offering; shares down 9% after hours</a></h4><ul><li>Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a>) is down <font color=\"red\">9%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17389563-wave-life-sciences-announces-proposed-public-offering-ordinary-shares\" target=\"_blank\">planned public offering</a> of ordinary shares. Price, volume and terms have yet to be announced.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">9%</font> premarket on Thursday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425375\" data-linked=\"Wave Life Sciences readies stock offering; shares down 9% after hours\" data-tweet=\"$WVE - Wave Life Sciences readies stock offering; shares down 9% after hours https://seekingalpha.com/news/3425375-wave-life-sciences-readies-stock-offering-shares-down-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3425375-wave-life-sciences-readies-stock-offering-shares-down-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425372\" data-ts=\"1548279891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXGN\" target=\"_blank\">NXGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425372-nextgen-fq3-revenues-flat-earnings-guidance-raised\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextGen FQ3 revenues flat, earnings guidance raised</a></h4><ul><li>NextGen Healthcare (NASDAQ:<a href='https://seekingalpha.com/symbol/NXGN' title='NextGen Healthcare Inc'>NXGN</a>) <a href=\"https://seekingalpha.com/pr/17389545-nextgen-healthcare-inc-reports-fiscal-2019-third-quarter-results\" target=\"_blank\">fiscal Q3 results</a> ($M): Total revenues: 130.9 (-0.6%), recurring revenues: 117.4 (-1.3%).</li><li>Net income: 4.8 (+213.0%); non-GAAP net income: 13.2 (+40.9%); EPS: 0.07 (+250.0%); non-GAAP EPS: 0.20 (+33.3%).</li><li><strong>Fiscal 2019 guidance</strong>: Revenues: $525M - 535M (unchanged but with a bias towards the lower end); non-GAAP EPS: $0.72 - 0.76 from $0.70 - 0.74.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425326-nextgen-healthcare-beats-0_05-misses-revenue\" target=\"_blank\">NextGen Healthcare beats by $0.05, misses on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425372\" data-linked=\"NextGen FQ3 revenues flat, earnings guidance raised\" data-tweet=\"$NXGN - NextGen FQ3 revenues flat, earnings guidance raised https://seekingalpha.com/news/3425372-nextgen-fq3-revenues-flat-earnings-guidance-raised?source=tweet\" data-url=\"https://seekingalpha.com/news/3425372-nextgen-fq3-revenues-flat-earnings-guidance-raised\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425370\" data-ts=\"1548279857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXGN\" target=\"_blank\">NXGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425370-nextgen-fq3-revenues-flat-earnings-guidance-raised\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextGen FQ3 revenues flat, earnings guidance raised</a></h4><ul><li>NextGen Healthcare (NASDAQ:<a href='https://seekingalpha.com/symbol/NXGN' title='NextGen Healthcare Inc'>NXGN</a>) <a href=\"https://seekingalpha.com/pr/17389545-nextgen-healthcare-inc-reports-fiscal-2019-third-quarter-results\" target=\"_blank\">fiscal Q3 results</a> ($M): Total revenues: 130.9 (-0.6%), recurring revenues: 117.4 (-1.3%).</li><li>Net income: 4.8 (+213.0%); non-GAAP net income: 13.2 (+40.9%); EPS: 0.07 (+250.0%); non-GAAP EPS: 0.20 (+33.3%).</li><li><strong>Fiscal 2019 guidance</strong>: Revenues: $525M - 535M (unchanged but with a bias towards the lower end); non-GAAP EPS: $0.72 - 0.76 from $0.70 - 0.74.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425326-nextgen-healthcare-beats-0_05-misses-revenue\" target=\"_blank\">NextGen Healthcare beats by $0.05, misses on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425370\" data-linked=\"NextGen FQ3 revenues flat, earnings guidance raised\" data-tweet=\"$NXGN - NextGen FQ3 revenues flat, earnings guidance raised https://seekingalpha.com/news/3425370-nextgen-fq3-revenues-flat-earnings-guidance-raised?source=tweet\" data-url=\"https://seekingalpha.com/news/3425370-nextgen-fq3-revenues-flat-earnings-guidance-raised\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425365\" data-ts=\"1548279648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425365-xilinxplus-8-on-q3-beats-upside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx +8% on Q3 beats, upside guide</a></h4><ul><li>Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) <font color=\"green\">gains 7.9%</font> aftermarket on Q3 beats with revenue up 34% Y/Y. Upside Q4 guidance has revenue from $815M to $835M (consensus: $776.2M).</li><li>Revenue breakdown (calculated from percentage of total revenue): Data Center and TME, $168M (consensus: $170.4M); Auto, Broadcast, and Consumer, $120M (consensus: $118.8M); Communications, $280M (consensus: $265.8M); Industrial, Aerospace, and Defense, $216M (consensus: $198.2M); Channel, $16M (consensus: $19.8M).</li><li>Earnings call is scheduled for 5 PM ET with a webcast available <a href=\"http://investor.xilinx.com/investor-relations\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17389554-xilinx-reports-record-revenues-eps-fiscal-third-quarter\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425327-xilinx-beats-0_07-beats-revenue\" target=\"_blank\">Xilinx beats by $0.07, beats on revenue</a> (Jan. 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425323-xilinx-declares-0_36-dividend\" target=\"_blank\">Xilinx declares $0.36 dividend</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425365\" data-linked=\"Xilinx +8% on Q3 beats, upside guide\" data-tweet=\"$XLNX - Xilinx +8% on Q3 beats, upside guide https://seekingalpha.com/news/3425365-xilinxplus-8-on-q3-beats-upside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3425365-xilinxplus-8-on-q3-beats-upside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425358\" data-ts=\"1548279351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425358-united-rentals-rides-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals rides higher after earnings</a></h4><ul> <li>United Rentals (NYSE:<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>) is <font color=\"green\">up 3.45%</font> after topping Q4 earnings estimates on the back of 21% rental revenue growth. Owned equipment rental revenue increased 18.8%, reflecting increases of 16.8% in the volume of equipment on rent and 2.2% in rental rates.</li> <li>Adjusted EBITDA increased 18.0% to a company record $1.117B.</li><li>The company's adjusted EBITDA margin fell 90 bps to 48.4% of sales as acquisitions factored in.</li> <li>Gross margin increased 30 bps to 43.3% of sales.</li> <li>CEO update: \"Our integration of major acquisitions expanded our service offering, and we gained traction from investments in fleet and technology. For the full year, we grew pro forma rental revenue by 10.5%, improved our adjusted EBITDA margin, and increased ROIC to a record 11%.\"</li> <li>Looking ahead, United Rentals expects 2019 revenue of $9.15B to $9.55B and adjusted EBITDA of $4.35B to $4.55B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425358\" data-linked=\"United Rentals rides higher after earnings\" data-tweet=\"$URI - United Rentals rides higher after earnings https://seekingalpha.com/news/3425358-united-rentals-rides-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3425358-united-rentals-rides-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425356\" data-ts=\"1548279239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCNA\" target=\"_blank\">NCNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425356-nucana-down-8-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuCana down 8% after hours on equity offering</a></h4><ul><li>NuCana (NASDAQ:<a href='https://seekingalpha.com/symbol/NCNA' title='NuCana plc'>NCNA</a>) is off <font color=\"red\">8%</font> after hours in response to its planned <a href=\"https://seekingalpha.com/pr/17389443-nucana-plc-announces-proposed-public-offering-adss\" target=\"_blank\">$75M offering</a> of American Depositary Shares (ADSs), each representing one ordinary share. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425356\" data-linked=\"NuCana down 8% after hours on equity offering\" data-tweet=\"$NCNA - NuCana down 8% after hours on equity offering https://seekingalpha.com/news/3425356-nucana-down-8-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3425356-nucana-down-8-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425355\" data-ts=\"1548279153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGG\" target=\"_blank\">BGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425355-briggs-and-amp-stratton-misses-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Briggs &amp;amp; Stratton misses by $0.05, beats on revenue</a></h4><ul><li>Briggs &amp; Stratton (NYSE:<a href='https://seekingalpha.com/symbol/BGG' title='Briggs & Stratton Corporation'>BGG</a>): Q2 Non-GAAP EPS of $0.20 <span style=\"color:red\">misses by $0.05</span>; GAAP EPS of -$0.07 <span style=\"color:red\">misses by $0.24</span>.</li><li>Revenue of $505.46M (+13.2% Y/Y) <font color=\"green\">beats by $43.75M</font>.</li><li>Shares <font color=\"green\">+1.46%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17389572-briggs-and-stratton-corporation-reports-fiscal-2019-second-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425355\" data-linked=\"Briggs &amp;amp; Stratton misses by $0.05, beats on revenue\" data-tweet=\"$BGG - Briggs &amp; Stratton misses by $0.05, beats on revenue https://seekingalpha.com/news/3425355-briggs-and-amp-stratton-misses-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425355-briggs-and-amp-stratton-misses-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425345\" data-ts=\"1548278915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425345-lam-resarchplus-7-on-q2-beats-5b-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam Resarch +7% on Q2 beats, $5B buyback</a></h4><ul><li>Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>) <font color=\"green\">gains 6.6%</font> after reporting Q2 results that beat EPS and revenue estimates with a 2% Y/Y revenue decline.</li><li>In-line Q3 guidance has revenue of $2.25B to $2.55B (consensus: $2.45B) and EPS of $3.20 to $3.60 (consensus: $3.38).</li><li>Gross margin was 46.3% (consensus: 46%) and operating margin was 28.8% (consensus: 27.5%).</li><li>Ending deferred revenue was $493M compared to the $626M in Q1.</li><li>Buyback: Lam's board <a href=\"https://seekingalpha.com/pr/17389512-lam-research-corporation-announces-5-billion-share-repurchase-authorization\" target=\"_blank\">approves </a>a $5B share repurchase program that will be funded from a combination of cash on hand, cash generation, and borrowings.</li><li>Suppliers getting a boost from Lam's earnings: Ichor (NASDAQ:<a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a>) +5.9%, MKS Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a>) <font color=\"green\">+0.2%</font>, Advanced Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a>) <font color=\"green\">+0.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17389506-lam-research-corporation-reports-financial-results-quarter-ended-december-23-2018\" target=\"_blank\">Press release.</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3425312-lam-research-beats-0_21-beats-revenue\" target=\"_blank\">Lam Research beats by $0.21, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425345\" data-linked=\"Lam Resarch +7% on Q2 beats, $5B buyback\" data-tweet=\"$LRCX $LRCX $ICHR - Lam Resarch +7% on Q2 beats, $5B buyback https://seekingalpha.com/news/3425345-lam-resarchplus-7-on-q2-beats-5b-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3425345-lam-resarchplus-7-on-q2-beats-5b-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425341\" data-ts=\"1548278771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425341-ford-trickles-higher-after-mixed-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford trickles higher after mixed quarter</a></h4><ul> <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) posts mixed results for a noisy Q4 that included a $1.8B special items charge. Revenue was ahead of estimates, while EPS arrived in $0.02 short.</li> <li>During the quarter, company adjusted EBIT of $1.5Bwas driven by North America, which posted fourth-quarter EBIT of $2.0B and an EBIT margin of 7.6%. Ford management also cited mix and pricing as positive factor during the quarter.</li> <li>\"While 2018 was a challenging year, we put in place key building blocks to build a more resilient and competitive business model that can thrive no matter the economic environment,\" says Ford CFO Bob Shanks.</li> <li>Shares of Ford are <font color=\"green\">up 0.60%</font> in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425333-ford-motor-misses-0_01-beats-revenue\" target=\"_blank\">Ford Motor misses by $0.01, beats on revenue</a> (Jan. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425341\" data-linked=\"Ford trickles higher after mixed quarter\" data-tweet=\"$F - Ford trickles higher after mixed quarter https://seekingalpha.com/news/3425341-ford-trickles-higher-after-mixed-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3425341-ford-trickles-higher-after-mixed-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425329\" data-ts=\"1548278537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADXS\" target=\"_blank\">ADXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425329-fda-halts-recruitment-in-advaxis-late-stage-study-of-axal-in-cervical-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA halts recruitment in Advaxis late-stage study of AXAL in cervical cancer</a></h4><ul><li>The FDA has placed a <a href=\"https://seekingalpha.com/pr/17389450-advaxis-phase-3-aim2cerv-study-placed-partial-clinical-hold-fda-related-cmc-requests\" target=\"_blank\">partial clinical hold</a> on Advaxis' (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis Inc.'>ADXS</a>) Phase 3 clinical trial evaluating axalimogene filolisbac &#40;AXAL&#41; in patients with high-risk locally advanced cervical cancer. The agency took action, which suspends the recruitment of new patients in the study, until it receives and reviews additional Chemistry, Manufacturing and Controls &#40;CMC&#41; information. There are no issues with product safety. Current participants may continue receiving treatment.</li><li><a href=\"http://www.advaxis.com/areas-of-focus/clinical-therapies/hpv/axalimogene-filolisbac/\" target=\"_blank\">Axalimogene filolisbac</a> is an immunotherapy based on the company's <a href=\"http://www.advaxis.com/technology/lm-technology\" target=\"_blank\">Lm Technology</a>, which uses live attenuated bioengineered <em>Listeria </em>bacteria to deliver a fusion protein inside cancer cells which then stimulates the immune system to attack the cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425329\" data-linked=\"FDA halts recruitment in Advaxis late-stage study of AXAL in cervical cancer\" data-tweet=\"$ADXS - FDA halts recruitment in Advaxis late-stage study of AXAL in cervical cancer https://seekingalpha.com/news/3425329-fda-halts-recruitment-in-advaxis-late-stage-study-of-axal-in-cervical-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3425329-fda-halts-recruitment-in-advaxis-late-stage-study-of-axal-in-cervical-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425327\" data-ts=\"1548278497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425327-xilinx-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx beats by $0.07, beats on revenue</a></h4><ul><li>Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>): Q3 Non-GAAP EPS of $0.92 <span style=\"color:green\">beats by $0.07</span>; GAAP EPS of $0.93 <span style=\"color:green\">beats by $0.08</span>.</li><li>Revenue of $800M (+33.6% Y/Y) <font color=\"green\">beats by $29.57M</font>.</li><li>Shares <font color=\"green\">+5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17389554-xilinx-reports-record-revenues-eps-fiscal-third-quarter\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425327\" data-linked=\"Xilinx beats by $0.07, beats on revenue\" data-tweet=\"$XLNX - Xilinx beats by $0.07, beats on revenue https://seekingalpha.com/news/3425327-xilinx-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425327-xilinx-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425320\" data-ts=\"1548278400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVS\" target=\"_blank\">LVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425320-las-vegas-sandsminus-4-after-earnings-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Las Vegas Sands -4% after earnings disappoint</a></h4><ul>  <li>Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) trades lower after missing with its Q4 report..</li>  <li>Net income was $2.95B during the quarter and consolidated EBITDA was $1.27B (-4.7% Y/Y).</li>  <li>The Sands China business recorded revenue growth of 9% to $2.25 vs. $2.17B consensus and property EBITDA of $786M (+7.7%) vs. $792M consensus.</li>  <li>Las Vegas properties generated revenue of $424M vs. $433M a year ago and $423M consensus. Vegas hold-normalized adjusted property EBITDA increased 9.6% to $125M.</li>  <li>\"We remain confident in the future opportunity in Macao and are progressing with our investments in the Four Seasons Tower Suites Macao, St. Regis Tower Suites Macao and The Londoner Macao021,\" says CEO Sheldon Adelson..</li>   <li>Shares of LVS are <font color=\"red\">down 4.37%</font> in AH trading to $54.75.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425320\" data-linked=\"Las Vegas Sands -4% after earnings disappoint\" data-tweet=\"$LVS - Las Vegas Sands -4% after earnings disappoint https://seekingalpha.com/news/3425320-las-vegas-sandsminus-4-after-earnings-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3425320-las-vegas-sandsminus-4-after-earnings-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425314\" data-ts=\"1548278250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425314-united-rentals-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals beats by $0.01, beats on revenue</a></h4><ul><li>United Rentals (NYSE:<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>): Q4 Non-GAAP EPS of $4.85 <span style=\"color:green\">beats by $0.01</span>; GAAP EPS of $3.80 <span style=\"color:red\">misses by $0.52</span>.</li><li>Revenue of $2.31B (+20.3% Y/Y) <font color=\"green\">beats by $90M</font>.</li><li>Shares <font color=\"green\">+5.07%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17389521-united-rentals-announces-fourth-quarter-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425314\" data-linked=\"United Rentals beats by $0.01, beats on revenue\" data-tweet=\"$URI - United Rentals beats by $0.01, beats on revenue https://seekingalpha.com/news/3425314-united-rentals-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425314-united-rentals-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425312\" data-ts=\"1548278210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRCX\" target=\"_blank\">LRCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425312-lam-research-beats-0_21-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lam Research beats by $0.21, beats on revenue</a></h4><ul><li>Lam Research (NASDAQ:<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a>): Q2 Non-GAAP EPS of $3.87 <span style=\"color:green\">beats by $0.21</span>; GAAP EPS of $3.51 <span style=\"color:green\">beats by $0.04</span>.</li><li>Revenue of $2.52B (-2.3% Y/Y) <font color=\"green\">beats by $20M</font>.</li><li>Shares <font color=\"green\">+6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17389506-lam-research-corporation-reports-financial-results-quarter-ended-december-23-2018\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3425312\" data-linked=\"Lam Research beats by $0.21, beats on revenue\" data-tweet=\"$LRCX - Lam Research beats by $0.21, beats on revenue https://seekingalpha.com/news/3425312-lam-research-beats-0_21-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3425312-lam-research-beats-0_21-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425300\" data-ts=\"1548278030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRTX\" target=\"_blank\">VRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425300-vertex-boots-coo-over-personal-behavior\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex boots COO over &quot;personal behavior&quot;</a></h4><ul><li>Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>) has <a href=\"https://seekingalpha.com/pr/17389464-vertex-announces-departure-ian-smith-names-interim-cfo\" target=\"_blank\">fired </a>COO and CFO Ian Smith over \"personal behavior that violated Vertex's Code of Conduct.\"</li><li>Corporate Controller and Chief Accounting Officer Paul Silva will take over the CFO job on an interim basis until a permanent successor is appointed.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425300\" data-linked=\"Vertex boots COO over &quot;personal behavior&quot;\" data-tweet=\"$VRTX - Vertex boots COO over &quot;personal behavior&quot; https://seekingalpha.com/news/3425300-vertex-boots-coo-over-personal-behavior?source=tweet\" data-url=\"https://seekingalpha.com/news/3425300-vertex-boots-coo-over-personal-behavior\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425285\" data-ts=\"1548277624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425285-petrobras-rejects-latest-eig-backed-bid-for-oilfields-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras rejects latest EIG-backed bid for oilfields - Reuters</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+1.9%</font>) has <a href=\"https://www.reuters.com/article/us-petrobras-divestiture-exclusive/exclusive-petrobras-rejects-latest-eig-backed-bid-for-oilfields-sources-idUSKCN1PH27D\" target=\"_blank\">rejected</a> the latest bid by a local firm backed by P-E firm EIG Global Energy Partners to purchase a pair of shallow water oil assets, Reuters reports.</li><li>EIG-backed Ouro Preto Oleo e Gas entered exclusive talks with PBR in July to buy the Pampo and Enchova clusters in the Campos Basin off the coast of Rio de Janeiro, which were expected to fetch ~$1B.</li><li>Ouro Preto took advantage of a December rebidding process to cut its offer, due in part to a drop in oil prices, but PBR reportedly  was unhappy with the lower price and rejected the updated bid.</li><li>The setback underlines the slow, at times convoluted process surrounding PBR's divestments, which have often frustrated potential buyers, according to the report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425285\" data-linked=\"Petrobras rejects latest EIG-backed bid for oilfields - Reuters\" data-tweet=\"$PBR - Petrobras rejects latest EIG-backed bid for oilfields - Reuters https://seekingalpha.com/news/3425285-petrobras-rejects-latest-eig-backed-bid-for-oilfields-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3425285-petrobras-rejects-latest-eig-backed-bid-for-oilfields-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425270\" data-ts=\"1548275708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425270-microbot-secures-2_5m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot secures $2.5M capital raise</a></h4><ul><li>Nano cap Microbot Medical (<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color=\"green\">+43.9%</font>) has <a href=\"https://seekingalpha.com/pr/17389418-microbot-medical-inc-announces-2_5-million-registered-direct-offering-priced-market\" target=\"_blank\">agreed to sell</a> 250K shares of common stock at $10/share to institutional investors in a registered direct offering. Buyers will also receive one-year warrants to purchase up to the same number of shares at $10. Closing date is January 25.</li><li>The stock has been on a tear this month, up over five-fold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425270\" data-linked=\"Microbot secures $2.5M capital raise\" data-tweet=\"$MBOT - Microbot secures $2.5M capital raise https://seekingalpha.com/news/3425270-microbot-secures-2_5m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3425270-microbot-secures-2_5m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425258\" data-ts=\"1548273634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOXL\" target=\"_blank\">BOXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425258-ibm-and-dox-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM and DOX among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a>) <font color=\"green\">+43%</font>. Alpha and Omega Semiconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AOSL' title='Alpha and Omega Semiconductor Limited'>AOSL</a>) <font color=\"green\">+14%</font>. International Business Machines (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"green\">+8%</font>. iCAD (NASDAQ:<a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a>) <font color=\"green\">+9%</font>. Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>Helios and Matheson Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) <font color=\"red\">-15%</font>. Amdocs (NYSE:<a href='https://seekingalpha.com/symbol/DOX' title='Amdocs Ltd'>DOX</a>) <font color=\"red\">-10%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Tech Shs Sponsored American Depositary Receipt Repr 1 Sh'>LKCO</a>) <font color=\"red\">-9%</font>. Ability (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a>) <font color=\"red\">-9%</font>. Superconductor Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SCON' title='Superconductor Technologies Inc.'>SCON</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425258\" data-linked=\"IBM and DOX among notable tech movers\" data-tweet=\"$BOXL $BOXL $AOSL - IBM and DOX among notable tech movers https://seekingalpha.com/news/3425258-ibm-and-dox-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425258-ibm-and-dox-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425256\" data-ts=\"1548273519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APH\" target=\"_blank\">APH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425256-amphenolplus-2-despite-downside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amphenol +2% despite downside guidance</a></h4><ul><li>Amphenol (NYSE:<a href='https://seekingalpha.com/symbol/APH' title='Amphenol Corporation'>APH</a>) <font color=\"green\">gains 2%</font> after this morning's Q4 report beat EPS and revenue estimates with a 14% Y/Y revenue growth.</li><li>Downside Q1 guidance has revenue from $1.89B to $1.938B (consensus: $1.94B) and EPS of $0.86 to $0.88 (consensus: $0.90).</li><li>Downside FY19 guidance has revenue from $8.19B to $8.35B (consensus: $8.37B) and EPS of $3.88 to $3.96 (consensus: $3.99).</li><li>The company attributes the downside guides to global uncertainty due to the US-China trade war and lowered mobile market demand.</li><li><a href=\"https://seekingalpha.com/pr/17388451-fourth-quarter-2018-record-results-reported-amphenol-corporation\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425040-amphenol-beats-0_08-beats-revenue\" target=\"_blank\">Amphenol beats by $0.08, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425256\" data-linked=\"Amphenol +2% despite downside guidance\" data-tweet=\"$APH - Amphenol +2% despite downside guidance https://seekingalpha.com/news/3425256-amphenolplus-2-despite-downside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3425256-amphenolplus-2-despite-downside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425251\" data-ts=\"1548272734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425251-whirlpoolminus-6-after-analysts-dole-out-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool -6% after analysts dole out caution</a></h4><ul> <li>Whirpool (<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-5.6%</font>) drops after Goldman Sachs warns that 2019 EBIT guidance from the company may disappoint when it reports earnings next week.</li> <li>Buckingham Research is also out with a cautious note on Whirlpool (Neutral, $135 PT), highlighted by a general lack of confidence in a turnaround.</li> <li>Shares of Whirlpool are up 7% over the last 90 days after an extended slide when tariff-related price hikes cut into consumer demand for products.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425251\" data-linked=\"Whirlpool -6% after analysts dole out caution\" data-tweet=\"$WHR - Whirlpool -6% after analysts dole out caution https://seekingalpha.com/news/3425251-whirlpoolminus-6-after-analysts-dole-out-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3425251-whirlpoolminus-6-after-analysts-dole-out-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425227\" data-ts=\"1548271345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RES\" target=\"_blank\">RES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425227-rpc-incminus-5_5-after-weak-q4-cautious-2019-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RPC Inc. -5.5% after weak Q4, cautious 2019 outlook</a></h4><ul><li>RPC Inc. (<a href='https://seekingalpha.com/symbol/RES' title='RPC Inc.'>RES</a> <font color='red'>-5.6%</font>) plunges after reporting a wide miss on <a href=\"https://seekingalpha.com/news/3424979-rpc-misses-0_04-misses-revenue\" target=\"_blank\">Q4 earnings</a> and a 12% Y/Y decline in revenues, saying activity declined sequentially due to seasonal weakness, particularly in its pressure pumping service line, and weather also hurt activity in several markets.</li><li>Q4 operating profit of $19.7M tumbled 67.4 % Y/Y from $60.3M in the year-earlier quarter, and EBITDA fell 38.9% to $61.7M from $101.1M a year ago.</li><li>RPC says Q4's \"significant and unexpected\" decline in the price of oil has created uncertainty among its customers, prompting the company to take a \"cautious\" outlook regarding its own 2019 prospects.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425227\" data-linked=\"RPC Inc. -5.5% after weak Q4, cautious 2019 outlook\" data-tweet=\"$RES - RPC Inc. -5.5% after weak Q4, cautious 2019 outlook https://seekingalpha.com/news/3425227-rpc-incminus-5_5-after-weak-q4-cautious-2019-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3425227-rpc-incminus-5_5-after-weak-q4-cautious-2019-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425208\" data-ts=\"1548270410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425208-ciscos-appdynamics-expands-monitoring-vision-adds-new-capabilities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco&#39;s AppDynamics expands monitoring vision, adds new capabilities</a></h4><ul>   <li>Two years after being <a href=\"https://seekingalpha.com/news/3237240-cisco-systems-buy-private-appdynamics-3_7b\" target=\"_blank\">acquired by Cisco</a> (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color=\"green\">+1.6%</font>) on the eve of an IPO, AppDynamics is filling out its <a href=\"https://seekingalpha.com/pr/17388511-cisco-appdynamics-ignite-new-era-aiops-unveiling-vision-central-nervous-system\" target=\"_blank\">long-term strategy</a> for monitoring along with announcements of product enhancements.</li>    <li>It's part of what AppDynamics calls the \"Central Nervous System\" for IT, pursuing full visibility across the application, infrastructure and network areas.</li>    <li>Along with other acquisitions (including Cisco's purchase of Perspica), the company has developed a new Cognition Engine, promising the combination of AppDynamics' Business Transaction data model with machine-learning insights in order to provide performance diagnostics and root-cause analysis.</li>    <li>It also says that customers can leverage anomaly detection in the Cognition Engine to trigger automated remediation, addressing millions of actions every day such as opening tickets, sending messages and running automated remediation scripts.</li>    <li>In \"Visibility,\" AppDynamics says it's building on its already industry-leading performance with two new coverage areas: Its serverless agent allows for monitoring and managing AWS Lambda functions, and integration with Cisco's Application Centric Infrastructure gives correlated visibility through application and network teams.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425208\" data-linked=\"Cisco&#39;s AppDynamics expands monitoring vision, adds new capabilities\" data-tweet=\"$CSCO - Cisco&#39;s AppDynamics expands monitoring vision, adds new capabilities https://seekingalpha.com/news/3425208-ciscos-appdynamics-expands-monitoring-vision-adds-new-capabilities?source=tweet\" data-url=\"https://seekingalpha.com/news/3425208-ciscos-appdynamics-expands-monitoring-vision-adds-new-capabilities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425204\" data-ts=\"1548270304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425204-jefferies-bearish-on-biotechs-sees-6-near-term-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies bearish on biotechs, sees 6% near-term downside</a></h4><ul><li>Jefferies healthcare strategist Jared Holtz is a short-term biotech bear saying that profit-taking \"makes sense\" through this earnings season considering the sector's market-leading performance so far this year. He thinks the SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color=\"red\">-1.3%</font>) could drop to $75 (<font color=\"red\">-6%</font>) over the next few weeks.</li><li>Mr. Holtz believes the top biotechs have scant upside, adding that M&amp;A activity should continue albeit with more modest premiums that recent deals.</li><li>Selected tickers: <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a>, <a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a>, <a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>, <a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>, <a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>, <a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>, <a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>, <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>, <a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>, <a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a>, <a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a>, <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>, <a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>, <a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a>, <a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>, <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a>, <a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a>, <a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a>, <a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>, <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a>, <a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>, <a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>, <a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a>, <a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>, <a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a></li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3425204\" data-linked=\"Jefferies bearish on biotechs, sees 6% near-term downside\" data-tweet=\"$BIIB $XBI $XLV - Jefferies bearish on biotechs, sees 6% near-term downside https://seekingalpha.com/news/3425204-jefferies-bearish-on-biotechs-sees-6-near-term-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3425204-jefferies-bearish-on-biotechs-sees-6-near-term-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425202\" data-ts=\"1548269631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAT\" target=\"_blank\">TAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425202-transatlantic-petroleum-leads-energy-materials-gainers-legacy-reserves-and-sprague-resources\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransAtlantic Petroleum leads Energy/Materials gainers; Legacy Reserves and Sprague Resources among losers</a></h4><ul><li><b>Gainers: </b>TransAtlantic Petroleum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a>) <font color=\"green\">+14%</font>. Companhia Siderurgica Nacional (NYSE:<a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a>) <font color=\"green\">+6%</font>. Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>) <font color=\"green\">+6%</font>. Delta Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a>) <font color=\"green\">+5%</font>. ProPetro Holding (NYSE:<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro'>PUMP</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Seadrill Partners (NYSE:<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a>) <font color=\"red\">-15%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"red\">-14%</font>. Sprague Resources (NYSE:<a href='https://seekingalpha.com/symbol/SRLP' title='Sprague Resources LP'>SRLP</a>) <font color=\"red\">-13%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-11%</font>. SAExploration Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425202\" data-linked=\"TransAtlantic Petroleum leads Energy/Materials gainers; Legacy Reserves and Sprague Resources among losers\" data-tweet=\"$TAT $TAT $SID - TransAtlantic Petroleum leads Energy/Materials gainers; Legacy Reserves and Sprague Resources among losers https://seekingalpha.com/news/3425202-transatlantic-petroleum-leads-energy-materials-gainers-legacy-reserves-and-sprague-resources?source=tweet\" data-url=\"https://seekingalpha.com/news/3425202-transatlantic-petroleum-leads-energy-materials-gainers-legacy-reserves-and-sprague-resources\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425201\" data-ts=\"1548269559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NHTC\" target=\"_blank\">NHTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425201-p-and-g-results-lift-personal-product-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">P&amp;G results lift personal product stocks</a></h4><ul> <li>A number of personal product stocks are following Procter &amp; Gamble higher after the company's price hikes led to a 4% gain in organic sales in Q4 and strong results in the beauty segment. The upward movement for the related names arrives with the S&amp;P 500 Index down slightly for the day.</li> <li>Gainers include Natural Health Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/NHTC' title='Natural Health Trends Corp.'>NHTC</a>) <font color=\"green\">+3.7%</font>, Inter Parfums (NASDAQ:<a href='https://seekingalpha.com/symbol/IPAR' title='Inter Parfums, Inc.'>IPAR</a>) <font color=\"green\">+1.7%</font>, Unilever (NYSE:<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a>) <font color=\"green\">+1.3%</font>, e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) <font color=\"green\">+1.0%</font>, L'Oreal (<a href='https://seekingalpha.com/symbol/LRLCF' title='L&#39;Oreal Co.'>OTCPK:LRLCF</a>) <font color=\"green\">+2.7%</font>, Sally Beauty Holdings (NYSE:<a href='https://seekingalpha.com/symbol/SBH' title='Sally Beauty Holdings, Inc.'>SBH</a>) <font color=\"green\">+1.3%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425201\" data-linked=\"P&amp;G results lift personal product stocks\" data-tweet=\"$NHTC $NHTC $IPAR - P&amp;G results lift personal product stocks https://seekingalpha.com/news/3425201-p-and-g-results-lift-personal-product-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3425201-p-and-g-results-lift-personal-product-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425198\" data-ts=\"1548268338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GFF\" target=\"_blank\">GFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425198-griffon-gets-gabelli-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Griffon gets Gabelli boost</a></h4><ul><li>Appearing on CNBC, Mario Gabelli says Griffon (<a href='https://seekingalpha.com/symbol/GFF' title='Griffon Corporation'>GFF</a> <font color='green'>+2.8%</font>) could <font color=\"green\">rise 50%</font> over the next 12-18 months.</li><li>Gabelli's Gamco is a holder of about 15% of Griffon shares, according to Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3425198\" data-linked=\"Griffon gets Gabelli boost\" data-tweet=\"$GFF - Griffon gets Gabelli boost https://seekingalpha.com/news/3425198-griffon-gets-gabelli-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3425198-griffon-gets-gabelli-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425188\" data-ts=\"1548267138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425188-facebooks-sandberg-zuckerberg-needs-to-remain-ceo-chairman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook&#39;s Sandberg: Zuckerberg needs to remain CEO/chairman</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"red\">-2.2%</font>) CEO Mark Zuckerberg has gotten a new vote of confidence from his second-in-command: Chief Operating Officer Sheryl Sandberg.</li>    <li>Speaking at the World Economic Forum in Davos, Sandberg says Zuckerberg should <a href=\"https://www.reuters.com/article/us-davos-meeting-facebook/facebooks-sandberg-says-zuckerberg-should-remain-ceo-chairman-idUSKCN1PH21H\" target=\"_blank\">remain atop the company</a> in his dual roles as chief executive and chairman, despite numerous calls for him to split the roles and hand off some power to more seasoned execs.</li>    <li>She also said the company needed to earn back public trust and that it was investing billions on network security.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3425188\" data-linked=\"Facebook&#39;s Sandberg: Zuckerberg needs to remain CEO/chairman\" data-tweet=\"$FB - Facebook&#39;s Sandberg: Zuckerberg needs to remain CEO/chairman https://seekingalpha.com/news/3425188-facebooks-sandberg-zuckerberg-needs-to-remain-ceo-chairman?source=tweet\" data-url=\"https://seekingalpha.com/news/3425188-facebooks-sandberg-zuckerberg-needs-to-remain-ceo-chairman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425185\" data-ts=\"1548266725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KLAC\" target=\"_blank\">KLAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425185-china-require-kla-orbotech-conditions-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China could require KLA/Orbotech conditions - report</a></h4><ul><li>DealReporter sources say KLA (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA Corporation'>KLAC</a> <font color=\"red\">-1.9%</font>) is still working with Chinese third parties to address issues with its purchase of Orbotech (<a href='https://seekingalpha.com/symbol/ORBK' title='Orbotech Ltd.'>ORBK</a> <font color=\"red\">-1%</font>).</li><li>China\u2019s State Administration for Market Regulation reportedly hasn't decided if it will impose conditions on the deal.</li><li>The regulators need to approve the deal before the March 18 termination deadline.</li><li>Source: Bloomberg First Word.</li><li>KLA announced its <a href=\"https://seekingalpha.com/news/3340122-kla-tencor-acquires-orbotech-3_4b\" target=\"_blank\">$3.4B Orbotech purchase</a> last March but <a href=\"https://seekingalpha.com/news/3419065-kla-tencor-still-seeks-china-merger-nod-orbk-minus-4-percent\" target=\"_blank\">last month</a> the companies announced discussions were still underway with Chinese regulators. The review had started in July.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425185\" data-linked=\"China could require KLA/Orbotech conditions - report\" data-tweet=\"$KLAC $KLAC $ORBK - China could require KLA/Orbotech conditions - report https://seekingalpha.com/news/3425185-china-require-kla-orbotech-conditions-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3425185-china-require-kla-orbotech-conditions-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425182\" data-ts=\"1548266449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYF\" target=\"_blank\">SYF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425182-synchrony-financial-leads-financial-gainers-triumph-bancorp-and-capital-one-financial-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchrony Financial leads financial gainers; Triumph Bancorp and Capital One Financial among losers</a></h4><ul><li><b>Gainers: </b>Synchrony Financial (NYSE:<a href='https://seekingalpha.com/symbol/SYF' title='Synchrony Financial'>SYF</a>) <font color=\"green\">+9%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+9%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>China Commercial Credit (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"red\">-17%</font>. Triumph Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/TBK' title='Triumph Bancorp'>TBK</a>) <font color=\"red\">-7%</font>. Manning &amp; Napier (NYSE:<a href='https://seekingalpha.com/symbol/MN' title='Manning & Napier'>MN</a>) <font color=\"red\">-6%</font>. Capital One Financial (NYSE:<a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a>) <font color=\"red\">-6%</font>. China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425182\" data-linked=\"Synchrony Financial leads financial gainers; Triumph Bancorp and Capital One Financial among losers\" data-tweet=\"$SYF $SYF $EHTH - Synchrony Financial leads financial gainers; Triumph Bancorp and Capital One Financial among losers https://seekingalpha.com/news/3425182-synchrony-financial-leads-financial-gainers-triumph-bancorp-and-capital-one-financial-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3425182-synchrony-financial-leads-financial-gainers-triumph-bancorp-and-capital-one-financial-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425181\" data-ts=\"1548266268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGFMF\" target=\"_blank\">AGFMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425181-agf-managementplus-11-after-q4-shows-mutual-fund-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AGF Management +11% after Q4 shows mutual fund sales</a></h4><ul><li>Thinly traded AGF Management (<a href='https://seekingalpha.com/symbol/AGFMF' title='AGF Management Ltd.'>OTCPK:AGFMF</a>) <font color=\"green\">leaps 11%</font> after reporting <a href=\"https://seekingalpha.com/pr/17388479-agf-management-limited-reports-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Q4 adjusted EPS </a>of C$0.17 (US$0.13) increases from C$0.11 a year ago.</li><li>Some 2,300 shares changed hands, almost three times its three-month average daily volume of 781.</li><li>Q4 net mutual fund sales of C$111M compares with redemptions of C$9M in Q3 and redemptions of C$139M in the year-ago quarter.</li><li>Total AUM, including alternative asset management platform, at Nov. 30, 2018 of C$37.7B vs. C$38.8B at Aug. 31, 2018 and C$37.3B at Nov. 30, 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425060-agf-management-reports-q4-results\" target=\"_blank\">AGF Management reports Q4 results</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425181\" data-linked=\"AGF Management +11% after Q4 shows mutual fund sales\" data-tweet=\"$AGFMF - AGF Management +11% after Q4 shows mutual fund sales https://seekingalpha.com/news/3425181-agf-managementplus-11-after-q4-shows-mutual-fund-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3425181-agf-managementplus-11-after-q4-shows-mutual-fund-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425177\" data-ts=\"1548265524\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOXL\" target=\"_blank\">BOXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425177-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a>) <font color=\"green\">+47%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"green\">+33%</font>. Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+33%</font>. Blink Charging (NASDAQ:<a href='https://seekingalpha.com/symbol/BLNK' title='Blink Charging Co.'>BLNK</a>) <font color=\"green\">+27%</font>. iFresh (NASDAQ:<a href='https://seekingalpha.com/symbol/IFMK' title='iFresh Inc.'>IFMK</a>) <font color=\"green\">+18%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp'>PLAG</a>) <font color=\"green\">+15%</font>. Daxor Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corp'>DXR</a>) <font color=\"green\">+16%</font>. XTL Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a>) <font color=\"green\">+15%</font>. TransAtlantic Petroleum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a>) <font color=\"green\">+14%</font>. Alpine Immune Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ALPN' title='Alpine Immune Sciences, Inc.'>ALPN</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers: </strong>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) <font color=\"red\">-43%</font>. Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences'>SELB</a>) <font color=\"red\">-21%</font>. China Commercial Credit (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Commercial Credit, Inc.'>GLG</a>) <font color=\"red\">-17%</font>. Quotient Technology (NYSE:<a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a>) <font color=\"red\">-16%</font>. China SXT Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SXTC' title='China SXT Pharmaceuticals, Inc.'>SXTC</a>) <font color=\"red\">-15%</font>. Seadrill Partners (NYSE:<a href='https://seekingalpha.com/symbol/SDLP' title='Seadrill Partners, LLC'>SDLP</a>) <font color=\"red\">-14%</font>. LSI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LYTS' title='LSI Industries Inc.'>LYTS</a>) <font color=\"red\">-14%</font>. Cocrystal Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a>) <font color=\"red\">-14%</font>. Mersana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics'>MRSN</a>) <font color=\"red\">-14%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425177\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$BOXL $BOXL $MBOT - Microcaps mostly among midday movers https://seekingalpha.com/news/3425177-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425177-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425166\" data-ts=\"1548263266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425166-ibm-three-month-high-after-beat-analysts-cautious\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM at three-month high after beat, with analysts cautious</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a> is <font color=\"green\">up 7.9%</font> and hit its highest point since mid-October after yesterday's <a href=\"https://seekingalpha.com/news/3424840-ibm-plus-5-percent-q4-beats-upside-eps-guide\" target=\"_blank\">Q4 earnings topper</a> that featured some upside guidance for the coming fiscal year.</li>    <li>The move today is IBM's biggest earnings-related gain since Q3 of 2017.</li>    <li>That's despite revenues that slipped 3.5% and are still expected to decline this year (by another 2%), developments that have most analyst in \"show me\" mode, though they were mostly positive on the quarter.</li>    <li>For one, BMO's Keith Bachman raised his price target, to $147 from $145, and praised revenue growth in the areas that it did grow (not Systems or Global Financing) even with foreign exchange challenges. He's positive on management strategy and focus but unsure whether the Services business can grow.</li>    <li>That $147 target implies just over 11% upside.</li>    <li>On the other hand, Wells Fargo has lowered its target to $140 from $155 and sticking to a Market Perform outlook. Analyst Ed Caso says he expects a two-year pause to buybacks as free cash flow is used in the Red Hat acquisition, but also looks to steady progress with help from an increasing dividend rate and relatively high dividend yield and free cash flow yield.</li>    <li>Since the beginning of October, shares are <font color=\"red\">down more than 14%</font>, and they're <font color=\"red\">down 24.5%</font> over the past 12 months.</li>      <li><a href=\"https://seekingalpha.com/article/4234856-international-business-machines-corporation-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li>   <li><a href=\"https://seekingalpha.com/article/4234859-international-business-machines-ibm-management-q4-2018-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3425166\" data-linked=\"IBM at three-month high after beat, with analysts cautious\" data-tweet=\"$IBM - IBM at three-month high after beat, with analysts cautious https://seekingalpha.com/news/3425166-ibm-three-month-high-after-beat-analysts-cautious?source=tweet\" data-url=\"https://seekingalpha.com/news/3425166-ibm-three-month-high-after-beat-analysts-cautious\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425165\" data-ts=\"1548262876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFVN\" target=\"_blank\">LFVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425165-lifevantage-only-consumer-gainer-amira-nature-foods-and-trinseo-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LifeVantage only consumer gainer; Amira Nature Foods and Trinseo among losers</a></h4><ul><li><b>Gainers: </b>LifeVantage (NASDAQ:<a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Trinseo (NYSE:<a href='https://seekingalpha.com/symbol/TSE' title='Trinseo S.A.'>TSE</a>) <font color=\"red\">-11%</font>. Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color=\"red\">-8%</font>. Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods'>ANFI</a>) <font color=\"red\">-6%</font>. Summer Infant (NASDAQ:<a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a>) <font color=\"red\">-6%</font>. Marine Products (NYSE:<a href='https://seekingalpha.com/symbol/MPX' title='Marine Products Corporation'>MPX</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425165\" data-linked=\"LifeVantage only consumer gainer; Amira Nature Foods and Trinseo among losers\" data-tweet=\"$LFVN $LFVN $TSE - LifeVantage only consumer gainer; Amira Nature Foods and Trinseo among losers https://seekingalpha.com/news/3425165-lifevantage-only-consumer-gainer-amira-nature-foods-and-trinseo-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425165-lifevantage-only-consumer-gainer-amira-nature-foods-and-trinseo-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425160\" data-ts=\"1548262269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFNC\" target=\"_blank\">SFNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425160-simmons-first-nationalminus-4_1-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Simmons First National -4.1% post Q4 results</a></h4><div><ul><li>Simmons First National (<a href='https://seekingalpha.com/symbol/SFNC' title='Simmons First National Corporation'>SFNC</a> <font color=\"red\">-4.1%</font>) reports <a href=\"https://seekingalpha.com/pr/17387965-simmons-reports-record-2018-results\" target=\"_blank\">Q4</a> revenue growth of 5.4% Y/Y to $172.4M.</li><li>Return on average assets of 1.35% compared 0.54% Y/Y.</li><li>Return on average common equity of 9.98% or return on tangible common equity of 17.96%.</li><li>Efficiency ratio of 51.99% for Q4 &amp; 52.85% for 2018.</li><li>Total loans were $11.7B (+8.8% Y/Y); loan growth, excluding planned runoff of the indirect portfolio, of 10% on an annualized basis.</li><li>Total deposits were $12.4B (+11.8% Y/Y).</li><li>Net interest margin was 3.76%, a <font color=\"red\">22 bps decrease</font> from Q3 2018; core net interest margin, excluding the accretion, was 3.66%, a <font color=\"red\">5 bps decrease</font> from Q3 2018.</li><li>Common stockholders' equity was $2.2B; book value/share was $24.33 &amp; tangible book value/share was $14.18 .</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424889-simmons-first-national-misses-0_01-misses-revenue\" target=\"_blank\">Simmons First National misses by $0.01, misses on revenue</a> (Jan. 22)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3425160\" data-linked=\"Simmons First National -4.1% post Q4 results\" data-tweet=\"$SFNC - Simmons First National -4.1% post Q4 results https://seekingalpha.com/news/3425160-simmons-first-nationalminus-4_1-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3425160-simmons-first-nationalminus-4_1-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425155\" data-ts=\"1548261558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425155-fedex-and-ups-stumble-after-wsj-report-on-amazon-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx and UPS stumble after WSJ report on Amazon pricing</a></h4><ul> <li>FedEx (<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a> <font color='red'>-1.7%</font>) and UPS (<a href='https://seekingalpha.com/symbol/UPS' title='United Parcel Service, Inc.'>UPS</a> <font color='red'>-2.4%</font>) trade lower after <em>The Wall Street Journal</em> may cut down on the <a href=\"https://www.wsj.com/articles/amazons-pitch-to-woo-shippers-fewer-fees-than-fedex-ups-11548251763\" target=\"_blank\">extra fees</a> charged to shippers as part of its new seven-day delivery service.</li> <li>An Amazon e-mail sent to prospective customers indicated that end-to-end deliveries sent to homes during the peak season or on holiday weekends won't be tagged with extra charges. The WSJ notes that residential surcharge fees at FedEx average about $3.80 per parcel, while UPS is even higher at $3.95 per parcel. Amazon could also lighten up on fuel surcharge fees in a bid to poach customers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425155\" data-linked=\"FedEx and UPS stumble after WSJ report on Amazon pricing\" data-tweet=\"$FDX $FDX $UPS - FedEx and UPS stumble after WSJ report on Amazon pricing https://seekingalpha.com/news/3425155-fedex-and-ups-stumble-after-wsj-report-on-amazon-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3425155-fedex-and-ups-stumble-after-wsj-report-on-amazon-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425153\" data-ts=\"1548261480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROL\" target=\"_blank\">ROL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425153-rollins-down-4-post-q4-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rollins down 4% post Q4 earnings miss</a></h4><ul><li>Rollins (<a href='https://seekingalpha.com/symbol/ROL' title='Rollins Inc.'>ROL</a> <font color=\"red\">-4.9%</font>) reported Q4 revenue increase of 7.2% Y/Y to $444.62M and net income of $50.97M (+51.1% Y/Y).</li><li>Q4 EBITDA increased 5.1% Y/Y to 87.82M and <font color=\"red\">margin declined by 40 bps </font>to 19.7%.</li><li>SG&amp;A expenses increased 9.8% Y/Y to $135.76M and margin was 30.5% <font color=\"red\">up by 71 bps</font>.</li><li>Company has cash and cash equivalents of $115.48M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425011-rollins-misses-0_01-misses-revenue\" target=\"_blank\">Rollins misses by $0.01, misses on revenue</a> (Jan. 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424851-rollins-declares-0_105-dividend\" target=\"_blank\">Rollins declares $0.105 dividend</a> (Jan. 22)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425153\" data-linked=\"Rollins down 4% post Q4 earnings miss\" data-tweet=\"$ROL - Rollins down 4% post Q4 earnings miss https://seekingalpha.com/news/3425153-rollins-down-4-post-q4-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3425153-rollins-down-4-post-q4-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425152\" data-ts=\"1548261044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425152-youtube-tv-expands-virtually-nationwide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YouTube TV expands virtually nationwide</a></h4><ul>    <li>YouTube TV (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color=\"red\">-0.4%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color=\"red\">-0.4%</font>) is expanding to almost the entire country today, <a href=\"https://www.fiercevideo.com/cable/youtube-tv-going-nationwide-adding-95-new-markets\" target=\"_blank\">adding 95 markets and reaching 98% of U.S. households</a>.</li>    <li>It says the remaining households will follow shortly.</li>    <li>That brings it in line with other streaming live-TV rivals like DirecTV Now (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.8%</font>) and Sling TV (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"red\">-2.6%</font>).</li>    <li>More than 90% of the markets will have local affiliate coverage from the Big Four TV broadcasters.</li>    <li>YouTube TV is priced at $40/month and features more than 60 live channels, cloud DVR and support for up to six accounts. A short bit ago, Hulu announced it would <a href=\"https://seekingalpha.com/news/3425150-hulu-raises-live-tv-pricing-lowers-ad-supported-product-price\" target=\"_blank\">raise the price</a> of its live TV bundle to $44.99/month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425152\" data-linked=\"YouTube TV expands virtually nationwide\" data-tweet=\"$GOOG $GOOG $GOOGL - YouTube TV expands virtually nationwide https://seekingalpha.com/news/3425152-youtube-tv-expands-virtually-nationwide?source=tweet\" data-url=\"https://seekingalpha.com/news/3425152-youtube-tv-expands-virtually-nationwide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425150\" data-ts=\"1548260594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DIS\" target=\"_blank\">DIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425150-hulu-raises-live-tv-pricing-lowers-ad-supported-product-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hulu raises live TV pricing, lowers ad-supported product price</a></h4><ul>   <li>Fresh off of <a href=\"https://seekingalpha.com/news/3423089-netflix-plus-5-percent-report-price-hikes\" target=\"_blank\">Netflix price hikes</a>, Hulu is <a href=\"https://variety.com/2019/digital/news/hulu-price-increase-live-tv-lower-vod-ads-1203115482/\" target=\"_blank\">raising the price of its live television offering</a> while giving a break to its ad-supported on-demand product.</li>    <li>The streamer has raised the live TV bundle by $5 a month, to $44.99/month. Meanwhile, the ad-supported VOD service will see a $2 price cut, to $5.99/month from $7.99/month.</li>    <li>The ad-free tier of video on demand will remain unchanged at $11.99/month.</li>    <li>The moves are effective as of Feb. 26.</li>    <li>Hulu doesn't disclose exactly how its 25M subscribers break down, though it confirmed to <i>Variety</i> that the \"majority\" of customers are on the ad-supported on-demand plan, which is the one seeing the price cut.</li>    <li>Hulu -- for now -- is owned by Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"green\">+4.2%</font>), Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color=\"green\">+0.2%</font>) and WarnerMedia (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.7%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425150\" data-linked=\"Hulu raises live TV pricing, lowers ad-supported product price\" data-tweet=\"$DIS $DIS $FOX - Hulu raises live TV pricing, lowers ad-supported product price https://seekingalpha.com/news/3425150-hulu-raises-live-tv-pricing-lowers-ad-supported-product-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3425150-hulu-raises-live-tv-pricing-lowers-ad-supported-product-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425142\" data-ts=\"1548259476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425142-microbot-medical-leads-healthcare-gainers-rexahn-pharmaceuticals-tops-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers</a></h4><ul><li><b>Gainers: </b>Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"green\">+22%</font>. Alpine Immune Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ALPN' title='Alpine Immune Sciences, Inc.'>ALPN</a>) <font color=\"green\">+14%</font>. Daxor (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corp'>DXR</a>) <font color=\"green\">+13%</font>. Athersys (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a>) <font color=\"green\">+12%</font>.  Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) <font color=\"red\">-43%</font>. Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences'>SELB</a>) <font color=\"red\">-21%</font>. DBV Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies'>DBVT</a>) <font color=\"red\">-10%</font>. UroGen Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/URGN' title='UroGen Pharma'>URGN</a>) <font color=\"red\">-10%</font>. PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425142\" data-linked=\"Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers\" data-tweet=\"$MBOT $MBOT $ALPN - Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers https://seekingalpha.com/news/3425142-microbot-medical-leads-healthcare-gainers-rexahn-pharmaceuticals-tops-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425142-microbot-medical-leads-healthcare-gainers-rexahn-pharmaceuticals-tops-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425140\" data-ts=\"1548259234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425140-fireeyeplus-5_6-baird-looks-to-strong-2019-after-pullback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye +5.6% as Baird looks to strong 2019 after pullback</a></h4><ul>   <li>FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) is on its best day in several weeks, now <font color=\"green\">up 5.6%</font>, after Baird adds it to its Fresh Pick list.</li>    <li>Shares have declined recently and the firm expects 2019 guidance topping analyst estimates. with a \"breakout year\" ahead for key products like Managed Defense and iSight. Another catalyst could come from Expertise on Demand, where market traction is ahead of expectations. (h/t Bloomberg)</li>    <li>Baird has an Outperform rating and $23 price target, implying 35% upside.</li>    <li>Shares have <font color=\"red\">fallen 7.9%</font> over the past month, but are <font color=\"green\">up 7.5%</font> over the past 12 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425140\" data-linked=\"FireEye +5.6% as Baird looks to strong 2019 after pullback\" data-tweet=\"$FEYE - FireEye +5.6% as Baird looks to strong 2019 after pullback https://seekingalpha.com/news/3425140-fireeyeplus-5_6-baird-looks-to-strong-2019-after-pullback?source=tweet\" data-url=\"https://seekingalpha.com/news/3425140-fireeyeplus-5_6-baird-looks-to-strong-2019-after-pullback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425136\" data-ts=\"1548258752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425136-frontier-sells-nearly-100-towers-to-everest-for-80m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier sells nearly 100 towers to Everest for $80M</a></h4><ul>   <li>Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color=\"red\">-1.7%</font>) has divested nearly 100 wireless towers through a <a href=\"https://seekingalpha.com/pr/17388757-everest-infrastructure-partners-acquires-wireless-towers-frontier-communications\" target=\"_blank\">sale to Everest Infrastructure Partners</a>.</li>    <li>That sale comes for a reported $80M. The deal includes towers in 17 states, but heavily concentrated in Connecticut, New York, and California.</li>    <li>The deal makes Everest one of the largest private tower companies in the United States.</li>    <li>The towers are adjacent to Frontier Central Offices in many of the locations, making for easy access to transport service, and include spots in terrain and zoning challenged environments.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425136\" data-linked=\"Frontier sells nearly 100 towers to Everest for $80M\" data-tweet=\"$FTR - Frontier sells nearly 100 towers to Everest for $80M https://seekingalpha.com/news/3425136-frontier-sells-nearly-100-towers-to-everest-for-80m?source=tweet\" data-url=\"https://seekingalpha.com/news/3425136-frontier-sells-nearly-100-towers-to-everest-for-80m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425134\" data-ts=\"1548258470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425134-pier-one-imports-breaks-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier One Imports breaks out</a></h4><ul> <li>Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a>) is <font color=\"green\">up 9.0%</font> as shares continue a minor recovery from their low level of $0.27 late last month.</li> <li>The retailer is expected by some to fire off a reverse stock split to regain NYSE compliance.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425134\" data-linked=\"Pier One Imports breaks out\" data-tweet=\"$PIR - Pier One Imports breaks out https://seekingalpha.com/news/3425134-pier-one-imports-breaks-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3425134-pier-one-imports-breaks-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425133\" data-ts=\"1548258449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMED\" target=\"_blank\">SMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425133-sharps-compliance-up-6-post-q2-results-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sharps Compliance up 6% post Q2 results beat</a></h4><ul><li>Sharps Compliance (<a href='https://seekingalpha.com/symbol/SMED' title='SHARPS COMPLIANCE CORP'>SMED</a> <font color=\"green\">+6%</font>) reported Q2 revenue growth of 11.4% Y/Y to $12.39M, driven by increase in flu shot-related orders.</li><li>Q2 Gross margin <font color=\"green\">improved by 400 bps</font> to 32.2% and operating margin<font color=\"green\"> improved by 570 bps</font> to 6.7%.</li><li>Billings by Solutions: Mailbacks $8.12M (+20.3% Y/Y); Route-Based Pickup $2.08M (+13.6% Y/Y); Unused Medications $1.35M (+2.5% Y/Y); Third Party Treatment $78k (-76/9% Y/Y) and  Other $849k (+1.2% Y/Y).</li><li>EBITDA increased 148.1% Y/Y to $1.24M and margin <font color=\"green\">improved by 552 bps</font> to 10%.</li><li>SG&amp;A expenses increased 4.9% Y/Y to $2.96M and margin declined by 150 bps to 23.9%.</li><li>Company has Cash $6.4M, as of December 31, 2018 and working capital of $11.8M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424981-sharps-compliance-beats-0_02-beats-revenue\" target=\"_blank\">Sharps Compliance beats by $0.02, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425133\" data-linked=\"Sharps Compliance up 6% post Q2 results beat\" data-tweet=\"$SMED - Sharps Compliance up 6% post Q2 results beat https://seekingalpha.com/news/3425133-sharps-compliance-up-6-post-q2-results-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3425133-sharps-compliance-up-6-post-q2-results-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425132\" data-ts=\"1548258252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTX\" target=\"_blank\">UTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425132-united-technologies-outlook-not-baking-in-slowdown-worries-rbc-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Technologies outlook not baking in slowdown worries, RBC says</a></h4><ul><li>United Technologies (<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a> <font color=\"green\">+4.6%</font>) jumps as much as 7.5% after <a href=\"https://seekingalpha.com/news/3425014-united-technologies-plus-4-percent-q4-earnings-thump-estimates\" target=\"_blank\">Q4 results</a> and its full-year profit outlook beat consensus estimates.</li><li>RBC analyst Deane Dray says <a href=\"https://finance.yahoo.com/news/united-technologies-jumps-bigger-aerospace-125446216.html\" target=\"_blank\">investors should be encouraged</a> by UTX's \"solid\" 2019 guidance, and organic revenue guidance of 3%-5% indicates management is not baking  in any global slowdown; \"our expectation is that the extended two-year time frame for the spins  is likely to keep the stock somewhat range-bound,\" Dray says.</li><li>Barclays\u2019 Julian Mitchell says Q4 earnings beat UTX\u2019s  guidance largely due to a favorable tax rate and better Rockwell Collins results.</li><li>J.P. Morgan\u2019s Stephen Tusa says 2019 earnings guidance was above his estimate as well as consensus expectations, although segment profits look  slightly below at the midpoint on organic growth guidance, with  a lower than expected tax rate driving the headline EPS guidance beat.</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3425132\" data-linked=\"United Technologies outlook not baking in slowdown worries, RBC says\" data-tweet=\"$UTX - United Technologies outlook not baking in slowdown worries, RBC says https://seekingalpha.com/news/3425132-united-technologies-outlook-not-baking-in-slowdown-worries-rbc-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3425132-united-technologies-outlook-not-baking-in-slowdown-worries-rbc-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425129\" data-ts=\"1548258090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UCBI\" target=\"_blank\">UCBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425129-united-community-banksplus-2_7-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Community Banks +2.7% post Q4 results</a></h4><div><ul><li>United Community Banks (<a href='https://seekingalpha.com/symbol/UCBI' title='United Community Banks, Inc.'>UCBI</a> <font color=\"green\">+2.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17387966-united-community-banks-inc-announces-fourth-quarter-results\" target=\"_blank\">Q4</a> revenue growth of 14.9% Y/Y to $135.87M.</li><li>Return on assets of 1.43%, or 1.45% on adjusted basis.</li><li>Return on common equity of 12.1% or return on tangible common equity of 15.9%.</li><li>Loan growth, excluding planned runoff of the indirect portfolio, of 10% on an annualized basis.</li><li>Loan production was $868M (+34.8% Y/Y).</li><li>Expansion of the net interest margin to 3.97%, <font color=\"green\">up 2 bps</font> from 3Q 2018 and up <font color=\"green\">34 bps</font> Y/Y.</li><li>Efficiency ratio was 56.73%, or 55.83% on adjusted basis.</li><li>Net charge offs of 9 bps, consistent with last quarter\u2019s result of 7 bps.</li><li>NPAs of 0.20% of total assets, compared to 0.19% at September 30, 2018 and 0.23% at December 31, 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424890-united-community-banks-beats-0_02-misses-revenue\" target=\"_blank\">United Community Banks beats by $0.02, misses on revenue</a> (Jan. 22)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3425129\" data-linked=\"United Community Banks +2.7% post Q4 results\" data-tweet=\"$UCBI - United Community Banks +2.7% post Q4 results https://seekingalpha.com/news/3425129-united-community-banksplus-2_7-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3425129-united-community-banksplus-2_7-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425125\" data-ts=\"1548257031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425125-papa-johnsplus-6-after-buyout-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s +6% after buyout report</a></h4><ul> <li>Papa John's International (<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a> <font color=\"green\">+5.6%</font>) breaks higher after a speculative report from DealReporter suggests that Restaurants Brands International QSR could be interested in making a bid.</li> <li>DealReporter thinks ex-CEO John Schnatter and 3G Capital could partner up with Restaurant Brands on the buyout.</li> <li>Papa John's has traded as high as $44.50 this morning. Shares of PZZA were over $80 before Schnatter's damaging NFL comments.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425125\" data-linked=\"Papa John&#39;s +6% after buyout report\" data-tweet=\"$PZZA - Papa John&#39;s +6% after buyout report https://seekingalpha.com/news/3425125-papa-johnsplus-6-after-buyout-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3425125-papa-johnsplus-6-after-buyout-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425123\" data-ts=\"1548256632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425123-procter-gamble-earnings-call-highlights\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Procter &amp; Gamble earnings call highlights</a></h4><ul> <li>Procter &amp; Gamble (<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a> <font color='green'>+5.3%</font>) CFO Jon Moeller says the company isn't seeing a slowdown in China and remains \"fairly confident\" on growth in the second half of the year in the region.</li> <li>P&amp;G's solid organic sales growth in Q4 was boosted by a +30% gain in organic e-commerce sales.</li> <li>Segments showing strength in Q4 off new innovation include beauty and skin/personal care.</li> <li>The company expects to pay over $7B in dividends and repurchase up to $5B worth of shares.</li> <li><a href=\"https://services.choruscall.com/links/pg190123.html\" target=\"_blank\">Procter &amp; Gamble earnings call webcast</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3425006-organic-sales-solid-procter-and-gamble\" target=\"_blank\">Organic sales solid at Procter &amp; Gamble</a> (Jan. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425123\" data-linked=\"Procter &amp; Gamble earnings call highlights\" data-tweet=\"$PG - Procter &amp; Gamble earnings call highlights https://seekingalpha.com/news/3425123-procter-gamble-earnings-call-highlights?source=tweet\" data-url=\"https://seekingalpha.com/news/3425123-procter-gamble-earnings-call-highlights\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425117\" data-ts=\"1548255968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDY\" target=\"_blank\">TDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425117-on-teledyne-technologies-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Teledyne Technologies Q4 results</a></h4><ul><li>Teledyne Technologies (<a href='https://seekingalpha.com/symbol/TDY' title='Teledyne Technologies Inc'>TDY</a> <font color=\"green\">+0.7%</font>) reported Q4 sales growth of 6.2% Y/Y to $748.4M, reflecting sales increase in every segment.</li><li>Sales by segments: Instrumentation $263.4M (+3.4% Y/Y); Digital Imaging $225.9M (+9.3% Y/Y); Aerospace and Defense Electronics $178.3M (+2.8% Y/Y) and Engineered Systems $80.8M (+16.3% Y/Y).</li><li>Q4 Overall operating margin <font color=\"green\">expanded by 143 bps </font>to 14.8%.</li><li>SG&amp;A expenses increased by 2.9% Y/Y to $177.6M and margin <font color=\"green\">declined by 77 bps</font> to 23.7%.</li><li>Cash provided by operating activities was $125.5M, compared to $126.4M a year ago.</li><li>Q4 Free cash flow was $106.8M, compared to $108.4M a year ago.</li><li>1Q19 Outlook: Q1 GAAP EPS between $1.87-$1.92.</li><li>FY19 Outlook: GAAP EPS between $9.25-$9.35; and estimated tax rate of 22.3%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424988-teledyne-beats-0_27-beats-revenue\" target=\"_blank\">Teledyne beats by $0.27, beats on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425117\" data-linked=\"More on Teledyne Technologies Q4 results\" data-tweet=\"$TDY - More on Teledyne Technologies Q4 results https://seekingalpha.com/news/3425117-on-teledyne-technologies-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3425117-on-teledyne-technologies-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425118\" data-ts=\"1548255874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425118-soligenix-up-11-on-european-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Soligenix up 11% on European patent</a></h4><ul><li>Thinly traded nano cap Soligenix (<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color=\"green\">+10.7%</font>) is up on a healthy 45x surge in volume in reaction to its <a href=\"https://seekingalpha.com/pr/17388211-soligenix-receives-european-patent-dusquetide-related-innate-defense-regulator-analogs\" target=\"_blank\">receipt </a>of a new composition-of-matter patent in Europe protecting dusquetide, the active ingredient in SGX942, in Phase 3 development for oral mucositis in head &amp; neck cancer patients.</li><li>The European patent corresponds to a U.S. patent issued in August 2016.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425118\" data-linked=\"Soligenix up 11% on European patent\" data-tweet=\"$SNGX - Soligenix up 11% on European patent https://seekingalpha.com/news/3425118-soligenix-up-11-on-european-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/3425118-soligenix-up-11-on-european-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425108\" data-ts=\"1548254667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SELB\" target=\"_blank\">SELB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425108-selecta-bio-prices-stock-offering-1_50-shares-down-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selecta Bio prices stock offering at $1.50; shares down 22%</a></h4><ul><li>Thinly traded nano cap Selecta Biosciences (<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences'>SELB</a> <font color=\"red\">-21.6%</font>) is down on almost a 4x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17388879-selecta-biosciences-announces-pricing-public-offering-common-stock\" target=\"_blank\">public offering</a> of 20M common shares at $1.50 per share. Underwriters over-allotment is an additional 3M sharess. Closing date is January 25.</li><li>Yesterday's close was $1.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425108\" data-linked=\"Selecta Bio prices stock offering at $1.50; shares down 22%\" data-tweet=\"$SELB - Selecta Bio prices stock offering at $1.50; shares down 22% https://seekingalpha.com/news/3425108-selecta-bio-prices-stock-offering-1_50-shares-down-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3425108-selecta-bio-prices-stock-offering-1_50-shares-down-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425105\" data-ts=\"1548254331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425105-qualcommminus-3-on-new-short-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm -3% on new short report</a></h4><ul><li>\"Short activist\" fund Kerrisdale Capital is out with a new short report on Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://twitter.com/KerrisdaleCap/status/1088081401289814016\" target=\"_blank\">saying</a> that the company's \"imminent loss in its ongoing trial against the Federal Trade Commission is more serious\" than the Street thinks since it would end its \"extortion-level royalties.\"</li><li>Read the report <a href=\"https://www.kerrisdalecap.com/wp-content/uploads/2019/01/Qualcomm-Incorporated-QCOM.pdf\" target=\"_blank\">here</a>.</li><li>QCOM is <font color=\"red\">down 3%</font> to $52.65.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425105\" data-linked=\"Qualcomm -3% on new short report\" data-tweet=\"$QCOM - Qualcomm -3% on new short report https://seekingalpha.com/news/3425105-qualcommminus-3-on-new-short-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3425105-qualcommminus-3-on-new-short-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425095\" data-ts=\"1548253661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425095-melco-resorts-entertainmentplus-2-after-ho-comments-analyst-actions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melco Resorts &amp; Entertainment +2% after Ho comments, analyst actions</a></h4><ul> <li>Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) CEO Lawrence Ho says Macau revenue growth this year should fall in the mid-to-high single digit range. The forecast from Ho is higher than the estimates from some analysts covering the sector, per Bloomberg.</li>  <li>\"Although the recent manufacturing data started to turn negative, the overall consumer sentiment is still ok,\" notes Ho.</li> <li>Melco is on the radar of some investment firms today. Daiwa Securities initiates coverage on the casino stock with an Outperform rating and JPMorgan slides its price target to $24.</li><li>Shares of MLCO are <font color=\"green\">up 1.91%</font> in premarket trading to $21.35.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425095\" data-linked=\"Melco Resorts &amp; Entertainment +2% after Ho comments, analyst actions\" data-tweet=\"$MLCO - Melco Resorts &amp; Entertainment +2% after Ho comments, analyst actions https://seekingalpha.com/news/3425095-melco-resorts-entertainmentplus-2-after-ho-comments-analyst-actions?source=tweet\" data-url=\"https://seekingalpha.com/news/3425095-melco-resorts-entertainmentplus-2-after-ho-comments-analyst-actions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425094\" data-ts=\"1548253583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425094-rexahn-down-40-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn down 40% on equity offering</a></h4><ul> <li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) <a href=\"https://seekingalpha.com/pr/17388816-rexahn-announces-pricing-public-offering-common-stock-warrants\" target=\"_blank\">prices</a> its public offering of 10.75M common stock and warrants to purchase same amount of common shares at a combined offering price of $0.80 per share and related warrant, for gross proceeds of ~$8.6M.</li>   <li>Net proceeds will be used for further development of clinical programs, for working capital and general corporate purposes.</li>    <li>Closing date is January 25.</li><li>Shares are down <font color=\"red\">40%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3424883-rexahn-11-percent-hours-equity-offering\" target=\"_blank\">Rexahn down 11% after hours on equity offering</a> (Jan. 22)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425094\" data-linked=\"Rexahn down 40% on equity offering\" data-tweet=\"$RNN $REXN - Rexahn down 40% on equity offering https://seekingalpha.com/news/3425094-rexahn-down-40-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3425094-rexahn-down-40-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425093\" data-ts=\"1548253547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425093-jd-complus-1_9-goldman-eyes-solid-user-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com +1.9% as Goldman eyes solid user growth</a></h4><ul>   <li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com'>JD</a>) is <font color=\"green\">up 1.9%</font> premarket following bullish commentary from Goldman Sachs, which sees user growth holding up thanks to management attention.</li>    <li>An encouraging sign is JD Mall's reorganization and comments from its CEO on refocusing on the user experience, the firm says, a move that could push active customers over 360M this year. Data point to a November uptick in monthly active users, and Q4 and Q1 guidance are likely to show 20% revenue growth, meeting expectations. (h/t Bloomberg)</li>    <li>The firm is maintaining a Buy rating and $41 price target, implying 89% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425093\" data-linked=\"JD.com +1.9% as Goldman eyes solid user growth\" data-tweet=\"$JD - JD.com +1.9% as Goldman eyes solid user growth https://seekingalpha.com/news/3425093-jd-complus-1_9-goldman-eyes-solid-user-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3425093-jd-complus-1_9-goldman-eyes-solid-user-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425086\" data-ts=\"1548253058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425086-neovasc-reducer-shows-benefit-in-angina-patient\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc Reducer shows benefit in angina patient</a></h4><ul> <li>The Journal of the American College of Cardiology: Cardiovascular Interventions (\"JACC\") has <a href=\"https://seekingalpha.com/pr/17388375-neovasc-announces-peer-reviewed-publication-jacc-demonstrating-objective-evidence-improvement\" target=\"_blank\">published</a> a peer reviewed article, titled, \"Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina\" on the use of dipyridamole stress perfusion cardiac magnetic resonance (\"CMR\") assessing the performance of Neovasc's (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) Reducer, a medical device for the treatment of refractory angina.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li>       </ul><div class=\"tiny-share-widget\" data-id=\"3425086\" data-linked=\"Neovasc Reducer shows benefit in angina patient\" data-tweet=\"$NVCN - Neovasc Reducer shows benefit in angina patient https://seekingalpha.com/news/3425086-neovasc-reducer-shows-benefit-in-angina-patient?source=tweet\" data-url=\"https://seekingalpha.com/news/3425086-neovasc-reducer-shows-benefit-in-angina-patient\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425084\" data-ts=\"1548252917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425084-vipshopplus-4_6-keybanc-goes-to-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop +4.6% as KeyBanc goes to Overweight</a></h4><ul>   <li>Vipshop ADRs (NYSE:<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>) are <font color=\"green\">up 4.6%</font> premarket after a raise to Overweight by KeyBanc.</li>    <li>Analyst Hans Chung has set a price target at $10, implying 55% upside; Chung sees a margin-boosting mix shift toward apparel as well as increasing turnover as benefits.</li>    <li>The ADRs have <font color=\"red\">fallen 59.5%</font> in 12 months, though they've <font color=\"green\">rebounded 25%</font> in the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425084\" data-linked=\"Vipshop +4.6% as KeyBanc goes to Overweight\" data-tweet=\"$VIPS - Vipshop +4.6% as KeyBanc goes to Overweight https://seekingalpha.com/news/3425084-vipshopplus-4_6-keybanc-goes-to-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3425084-vipshopplus-4_6-keybanc-goes-to-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425082\" data-ts=\"1548252731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNGX\" target=\"_blank\">SNGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425082-utx-syf-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UTX, SYF among premarket gainers</a></h4><ul><li>Soligenix (NASDAQ:<a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a>) <font color=\"green\">+25%</font> on <a href=\"https://seekingalpha.com/news/3424972-soligenix-nabs-new-patent-europe\" target=\"_blank\">new patent</a> in Europe.</li><li>Athersys (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHX' title='Athersys, Inc.'>ATHX</a>) <font color=\"green\">+20%</font> on <a href=\"https://seekingalpha.com/news/3425016-athersys-18-percent-positive-data-multistem-cell-therapy-study\" target=\"_blank\">positive data</a> from MultiStem cell therapy study.</li><li>Synchrony Financial (NYSE:<a href='https://seekingalpha.com/symbol/SYF' title='Synchrony Financial'>SYF</a>) <font color=\"green\">+13% </font>on Q4 <a href=\"https://seekingalpha.com/news/3424973-synchrony-financial-beats-0_18-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Accuray (NASDAQ:<a href='https://seekingalpha.com/symbol/ARAY' title='Accuray Incorporated'>ARAY</a>) <font color=\"green\">+12%</font> on Q2 <a href=\"https://seekingalpha.com/news/3424820-accuray-beats-0_03-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Rigel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a>) <font color=\"green\">+11%</font> <a href=\"https://seekingalpha.com/news/3425025-rigel-pharma-teams-grifols-tavalisse-shares-9-percent-premarket\" target=\"_blank\">teams up</a> with Grifols on Tavalisse.</li><li>Restaurant Brands (NYSE:<a href='https://seekingalpha.com/symbol/QSR' title='Restaurant Brands International Inc.'>QSR</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3424987-restaurants-brands-updates-results-management-changes\" target=\"_blank\">updates</a> on results, management change.</li><li>International Business Machines (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <font color=\"green\">+7%</font> on Q4 <a href=\"https://seekingalpha.com/news/3424816-international-business-machines-beats-0_05-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+7%</font>.</li><li>Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3425070-medigus-7-percent-participating-european-consortium\" target=\"_blank\">participating</a> in a European consortium.</li><li>United Technologies (NYSE:<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a>) <font color=\"green\">+5%</font> on Q4 <a href=\"https://seekingalpha.com/news/3424989-united-technologies-beats-0_40-beats-revenue\" target=\"_blank\">earnings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425082\" data-linked=\"UTX, SYF among premarket gainers\" data-tweet=\"$SNGX $SNGX $ATHX - UTX, SYF among premarket gainers https://seekingalpha.com/news/3425082-utx-syf-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425082-utx-syf-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425081\" data-ts=\"1548252722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGR\" target=\"_blank\">PGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425081-progressiveminus-1_8-after-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progressive -1.8% after Q4 miss</a></h4><ul><li>Progressive (NYSE:<a href='https://seekingalpha.com/symbol/PGR' title='Progressive Corporation'>PGR</a>) <font color=\"red\">slips 1.8%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17388622-progressive-reports-december-2018-results-annual-dividend-amount\" target=\"_blank\">Q4 results </a>reflect $572.2M of pretax net realized losses on securities.</li><li>Q4 EPS of 44 cents misses consensus by 24 cents; compares with 98 cents a year ago.</li><li>Q4 net premiums written of $7.94B, up 18% from $6.75B in the year-ago quarter; net premiums earned rose 20% to $8.19B from $6.85B.</li><li>Total pretax net realized losses on securities of $572.2M vs. $9.7M loss in year-ago quarter.</li><li>Q4 combined ratio of 92.5% vs 91.4% Y/Y.</li><li>For month of December:</li></ul><ol><li>Net premiums written rose 20% to $2.36B Y/Y</li><li>Net premiums earned rose 19% to $2.55B from $2.14B.</li><li>EPS of 9 cents vs. 45 cents a year ago.</li><li>Total pretax net realized losses on securities $330.8M vs. loss of $12.6M a year ago.</li><li>Combined ratio of 80.5% vs. 90.7%.</li><li>Vehicle business policies in force: Total personal lines 17.8M, up 10% Y/Y; total commercial lines 696,900, up 8%;</li><li>Property business policies in force of 1.94M, up 32%.</li></ol><ul><li>Previously: <a href=\"https://seekingalpha.com/news/3425064-progressive-misses-0_24-misses-net-premiums-written\" target=\"_blank\">Progressive misses by $0.24, misses on net premiums written</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425081\" data-linked=\"Progressive -1.8% after Q4 miss\" data-tweet=\"$PGR - Progressive -1.8% after Q4 miss https://seekingalpha.com/news/3425081-progressiveminus-1_8-after-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3425081-progressiveminus-1_8-after-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425080\" data-ts=\"1548252715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DNR\" target=\"_blank\">DNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425080-denbury-resourcesplus-3-after-ruling-in-wyoming-helium-supply-contract-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Denbury Resources +3% after ruling in Wyoming helium supply contract case</a></h4><ul><li>Denbury Resources (NYSE:<a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a>) <font color=\"green\">+2.9%</font> pre-market after disclosing a generally favorable <a href=\"https://www.sec.gov/Archives/edgar/data/945764/000094576419000002/dnr-20190122xform8xkxapmtg.htm\" target=\"_blank\">trial court ruling</a> in the Riley Ridge helium supply contract case.</li><li>The court said DNR's performance was excused by the force majeure provisions of the contract for a 35-day period in 2014, but that the company should pay liquidated damages and interest as provided in the contract, which DNR estimates will total $39.8M plus $3.5M in interest.</li><li>DNR says it continues to believe its contractual obligations have been and continue to be excused by events that fall within the force majeure provisions in the helium supply contract.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425080\" data-linked=\"Denbury Resources +3% after ruling in Wyoming helium supply contract case\" data-tweet=\"$DNR - Denbury Resources +3% after ruling in Wyoming helium supply contract case https://seekingalpha.com/news/3425080-denbury-resourcesplus-3-after-ruling-in-wyoming-helium-supply-contract-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3425080-denbury-resourcesplus-3-after-ruling-in-wyoming-helium-supply-contract-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425079\" data-ts=\"1548252588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425079-rnn-and-ptct-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RNN and PTCT among premarket losers</a></h4><ul><li>Rexahn Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a>) <font color=\"red\">-36%</font> on <a href=\"https://seekingalpha.com/news/3424883-rexahn-11-percent-hours-equity-offering\" target=\"_blank\">announcing</a> equity offering.</li><li>Selecta Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences'>SELB</a>) <font color=\"red\">-25%</font> on <a href=\"https://seekingalpha.com/news/3424822-selecta-bio-readies-stock-offering-shares-13-percent-hours\" target=\"_blank\">announcing</a> stock offering.</li><li>Staffing 360 Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/STAF' title='Staffing 360 Solutions, Inc.'>STAF</a>) <font color=\"red\">-11%</font>.</li><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) <font color=\"red\">-9%</font> on <a href=\"https://seekingalpha.com/news/3425078-ptc-prices-stock-offering-30_20-shares-9-percent-premarket\" target=\"_blank\">pricing</a> stock offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425079\" data-linked=\"RNN and PTCT among premarket losers\" data-tweet=\"$RNN $REXN $SELB - RNN and PTCT among premarket losers https://seekingalpha.com/news/3425079-rnn-and-ptct-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3425079-rnn-and-ptct-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425078\" data-ts=\"1548252156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425078-ptc-prices-stock-offering-30_20-shares-down-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTC prices stock offering at $30.20; shares down 9% premarket</a></h4><ul><li>PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>) is down <font color=\"red\">9%</font> premarket on average volume in response to its <a href=\"https://seekingalpha.com/pr/17388677-ptc-therapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">public offering</a> of 6.72M common shares at $30.20 per share. Underwriters over-allotment is an additional ~1M shares. Closing date is January 25.</li><li>Yesterday's close was $33.02.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425078\" data-linked=\"PTC prices stock offering at $30.20; shares down 9% premarket\" data-tweet=\"$PTCT - PTC prices stock offering at $30.20; shares down 9% premarket https://seekingalpha.com/news/3425078-ptc-prices-stock-offering-30_20-shares-down-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3425078-ptc-prices-stock-offering-30_20-shares-down-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425072\" data-ts=\"1548251741\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYTS\" target=\"_blank\">LYTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425072-lsi-industries-down-6_9-on-q2-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LSI Industries down 6.9% on Q2 miss</a></h4><ul><li>LSI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LYTS' title='LSI Industries Inc.'>LYTS</a>) reports Graphics Segment net sales growth of 12% to $25.89M in <a href=\"https://seekingalpha.com/pr/17388609-lsi-industries-inc-reports-operating-results-second-quarter-declares-regular-cash-dividend\" target=\"_blank\">Q2</a>.</li><li>Lighting Segment net sales dropped 8% to $63.65M.</li><li>Gross margin rate down 540 bps to 22%.</li><li>Adjusted operating margin rate slipped 330 bps to 1.7% for the quarter.</li><li>LYTS <font color=\"red\">-6.9%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425059-lsi-industries-misses-0_09-misses-revenue\" target=\"_blank\">LSI Industries misses by $0.09, misses on revenue</a> (Jan. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3425072\" data-linked=\"LSI Industries down 6.9% on Q2 miss\" data-tweet=\"$LYTS - LSI Industries down 6.9% on Q2 miss https://seekingalpha.com/news/3425072-lsi-industries-down-6_9-on-q2-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3425072-lsi-industries-down-6_9-on-q2-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425071\" data-ts=\"1548251591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425071-goldman-says-lumentum-consensus-too-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman says Lumentum consensus too low</a></h4><ul><li>Goldman analyst Rod Hall thinks consensus estimates for Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) in 2019 are too low after reducing 3D sensor projections on Apple weakness.</li><li>Hall expects continuing weakness in Datacom but is looking for updates on the new low-cost CWDM4 transceiver and expansion into the chip business.</li><li>The analyst sees telecom as solid and lasers as stabilizing.</li><li>Rating maintained at Buy with the target cut from $87 to $69.</li><li>Source: Bloomberg First Word.</li><li>Lumentum shares are <font color=\"green\">up 0.9%</font> premarket to $45.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425071\" data-linked=\"Goldman says Lumentum consensus too low\" data-tweet=\"$LITE - Goldman says Lumentum consensus too low https://seekingalpha.com/news/3425071-goldman-says-lumentum-consensus-too-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3425071-goldman-says-lumentum-consensus-too-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425002\" data-ts=\"1548251223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425002-ubs-likes-lilly-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS likes Lilly in premarket analyst action</a></h4><ul><li>Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) initiated with Neutral rating at UBS.</li><li>Atara Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>) initiated with Buy rating and $62 (75% upside) price target at Mizuho.</li><li>Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco'>ELAN</a>) initiated with Sell rating at UBS.</li><li>Zoetis (NYSE:<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a>) initiated with Neutral rating at UBS.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) initiated with Buy rating at UBS.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) upgraded to Buy with a $131 (12% upside) price target at UBS.</li><li>Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>) initiated with Neutral rating at UBS.</li><li>AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) resumed with Neutral rating and $91 (3% upside) price target at UBS. Shares up <font color=\"green\">1%</font> premarket.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) reiterated at Overweight with a $50 (186% upside) price target at Piper Jaffray citing expected peak sales of RT002 of more than $1B.</li><li>La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a>) upgraded to Neutral with a $9 (50% upside) price target at JPMorgan. Shares up <font color=\"green\">5% </font>premarket.</li><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) upgraded to Neutral with a $16 (15% downside risk) price target at Piper Jaffray. Shares up <font color=\"green\">3%</font> premarket.</li><li>Merck (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) downgraded to Market Perform with an $80 (5% upside) pricer target at BMO. Shares down <font color=\"red\">1%</font> premarket.</li><li>Dova Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DOVA' title='Dova Pharmaceuticals'>DOVA</a>) downgraded to Underweight with a $20 (157% upside) price target at JPMorgan.</li><li>Editas Medicine (NASDAQ:<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a>) downgraded to Neutral at JPMorgan. Shares down <font color=\"red\">3%</font> premarket.</li><li>G1 Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GTHX' title='G1 Therapeutics'>GTHX</a>) downgraded to Neutral with a $41 (109% upside) price target at JPMorgan.</li><li>Eidos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/EIDX' title='Eidos Therapeutics'>EIDX</a>) downgraded to Neutral with a $34 (168% upside) price target at JPMorgan.</li><li>Apellis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/APLS' title='Apellis Pharmaceuticals, Inc.'>APLS</a>) downgraded to Neutral with a $34 (153% upside) price target at JPMorgan. Shares down <font color=\"red\">4%</font> premarket.</li><li>Mylan (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a>) downgraded to Neutral with a $32 (10% upside) price target at UBS. Shares down a fraction premarket.</li><li>Neurocrine Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>) downgraded to Neutral with a $100 (10% upside) price target at JPMorgan.</li><li>Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>) downgraded to Neutral with a $46 (9% upside) price target  at UBS. Shares down <font color=\"red\">1%</font> premarket.</li><li>ResMed (NYSE:<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a>) downgraded to Hold with a $123 (5% upside) price target at Deutsche Bank.</li></ul><div class=\"tiny-share-widget\" data-id=\"3425002\" data-linked=\"UBS likes Lilly in premarket analyst action\" data-tweet=\"$ALNY $ALNY $ATRA - UBS likes Lilly in premarket analyst action https://seekingalpha.com/news/3425002-ubs-likes-lilly-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3425002-ubs-likes-lilly-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425070\" data-ts=\"1548251149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGS\" target=\"_blank\">MDGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425070-medigus-up-7-on-fluorescent-colonoscope-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medigus up 7% on fluorescent colonoscope project</a></h4><ul> <li>Medigus (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a>) has <a href=\"https://seekingalpha.com/pr/17388393-medigus-participate-european-consortium-development-fluorescent-colonoscope-intended-improve\" target=\"_blank\">filed</a> an application under the framework of a consortium for a European grant for the development of a fluorescent colonoscope from Horizon 2020 fund.</li><li>The expected duration of the project is four years, with budget of \u20ac3M and intention to improve the ability of early detection of colorectal cancer.</li>  <li>In addition to Medigus, three universities from Germany and the Netherlands and a German company, are parties to the consortium.</li><li>Shares are up <font color=\"green\">7%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3425070\" data-linked=\"Medigus up 7% on fluorescent colonoscope project\" data-tweet=\"$MDGS - Medigus up 7% on fluorescent colonoscope project https://seekingalpha.com/news/3425070-medigus-up-7-on-fluorescent-colonoscope-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3425070-medigus-up-7-on-fluorescent-colonoscope-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3425065\" data-ts=\"1548250745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3425065-earnings-shakeup-in-household-products-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Earnings shakeup in household products sector</a></h4><ul> <li>Procter &amp; Gamble (NYSE:<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a>) is <font color=\"green\">up 4.2%</font> in premarket trading after the company appears to have navigated around FQ4 headwinds better than peer Kimberly-Clark.</li> <li>P&amp;G's organic sales growth of 4% topped KMB's mark of 3% amid higher pricing at both companies. Procter &amp; Gamble's operating margin of 22.8% easily topped the 16.2% reported by Kimberly-Clark for the quarter, with both companies battling through F/X challenges and commodity inflatiom.</li> <li>Colgate-Palmolive (NYSE:<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a>), Church &amp; Dwight (NYSE:<a href='https://seekingalpha.com/symbol/CHD' title='Church & Dwight Co Inc.'>CHD</a>) and Clorox (NYSE:<a href='https://seekingalpha.com/symbol/CLX' title='The Clorox Company'>CLX</a>) are on watch after the sector heavyweights reported. Shares of Kimberly-Clark have pared their early loss and are now <font color=\"red\">down 2.0%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425021-kimberly-clark-2_7-percent-post-q4-results\" target=\"_blank\">Kimberly-Clark down 2.7% post Q4 results</a> (Jan. 23)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3425006-organic-sales-solid-procter-and-gamble\" target=\"_blank\">Organic sales solid at Procter &amp; Gamble</a> (Jan. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3425065\" data-linked=\"Earnings shakeup in household products sector\" data-tweet=\"$PG $PG $CL - Earnings shakeup in household products sector https://seekingalpha.com/news/3425065-earnings-shakeup-in-household-products-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3425065-earnings-shakeup-in-household-products-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}